header logo image


Page 507«..1020..506507508509..520530..»

Blood screening Research, Opportunities, Emerging Trends, Competitive Strategies And Forecasts 2016-2028 – 3rd Watch News

June 13th, 2020 12:43 pm

A recent report published by QMI on blood screening market is a detailed assessment of the most important market dynamics. After carrying out thorough research on the market of blood screening historical as well as current growth parameters, business expectations for growth are obtained with utmost precision. The study identifies specific and important factors affecting the market for blood screening during the forecast period. It can enable manufacturers of blood screening to change their production and marketing strategies in order to envisage maximum growth. The market report on blood screening offers detailed information for stakeholders in the most comprehensive way on the current and future growth prospects of the demand for blood screening market.

To Request Sample Premium Reports: https://www.quincemarketinsights.com/request-sample-59139?utm_source=SSK&utm_medium=3WN&utm_campaign=SSK

This report provides comprehensive taxonomy and the description of industry-related products, applications and end-user channels for the blood screening market. This report also provides insight into market concepts for phase. This contains opportunity analysis which provides information on the most relevant macroeconomic and microeconomic factors affecting market revenues and estimates for the phase. The market background is discussed in the report which sheds a light on the key drivers, threats, patterns and opportunities in the demand for blood screening market. A global overview has been presented for blood screening products, supply chain analysis and hazard analysis, which is expected to help readers identify the key factors that support the growth of the demand for blood screening market. The report discusses the regulatory scenario affecting approvals for the products, across leading regions. It also provides information on the demand of the blood screening market adopted in leading countries. It includes a specific list of retailers and manufacturers dealing in blood screening market. Readers will also be able to find regional developments and regulations that impact market growth. Significant growth prospects are given for countries which also include key regional developments and factors that influence the growth of the demand for blood screening market. The report studies business patterns of top companys like- fujifilm holdings corporation, analogic corporation, siemens healthcare, esaote s.p.a, toshiba medical systems corporation, ge healthcare, philips healthcare, hitachi medical corporation, and mindray medical international ltd

Get TOC For The Overview Of The Premium Report: https://www.quincemarketinsights.com/request-toc-59139?utm_source=SSK&utm_medium=3WN&utm_campaign=SSK

Blood screening market growth is expected to gain high momentum during the forecast period due to increasing demand for imaging devices for diagnostics applications. An ceiling-mounted surgical lights is a medical imaging device, which uses high-frequency waves to visualize the internal organs of the body such as blood vessels, kidney, liver, human foetus, heart, etc. This market is gaining momentum, owing to the increase in the number of hospitals and adoption of technologically advanced devices, which can serve the purpose for both diagnostics and therapeutics. Moreover, the cumulative prevalence of cancer is driving the demand for early detections and minimization of expenses. According to the Cancer Research Institute (CRI), there were approximately 17 million new cases of cancer globally, as of 2017, which is also fuelling the demand for ultrasound devices.

Segment Analysis

The bed head multifunctional belt market has been segmented by technology (nucleic acid amplification, elisa, rapid test, western blot), by product (instrument, reagent & kits, software), by end user (blood bank, hospital). Based on portability, the market can be divided into trolley/cart and compact/handheld. Based on application, the market has been divided into radiology, gynaecology, urology, cardiology, orthopaedic/musculoskeletal, and others. Owing to the growing incidences of stem cell-based injuries and the demand for high-quality diagnostic procedures, the radiology segment is expected to lead. The market has been studied for North America, Western Europe, Eastern Europe, Asia Pacific, and Rest of the World.

Key Factors Impacting Market Growth:

Regional Outlook:

North America, Western Europe, and Asia Pacific by region are estimated to dominate the ultrasound market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favourable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for ultrasound market during the forecast period.

The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for ultrasound market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for ultrasound market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for ultrasound during the forecast period.

Speak To Analyst before Buying This: https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-59139?utm_source=SSK&utm_medium=3WN&utm_campaign=SSK

Market Segmentation:

By Technology:

North America, by Country

US

Canada

Mexico

North America, by Product

North America, by End-User

North America, by Technology

Western Europe, by Country

Germany

UK

France

Italy

Spain

The Netherlands

Rest of Western Europe

Western Europe, by Product

Western Europe, by End-User

Western Europe, by Technology

Asia Pacific, by Country

China

India

Japan

South Korea

Australia

Indonesia

Rest of Asia Pacific

Asia Pacific, by Product

Asia Pacific, by End-User

Asia Pacific, by Technology

Eastern Europe, by Country

Russia

Turkey

Rest of Eastern Europe

Eastern Europe, by Product

Eastern Europe, by End-User

Eastern Europe, by Technology

Middle East, by Country

UAE

Saudi Arabia

Qatar

Iran

Rest of Middle East

Middle East, by Product

Middle East, by End-User

Middle East, by Technology

Rest of the World, by Country

South America

Africa

Rest of the World, by Product

Rest of the World, by End-User

Rest of the World, by Technology

Major Companies: Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics, Inc., Becton, Dickinson and Company (, DiaSorin, GFE, Trinity Biotech, Merck Millipore, GE Healthcare.

Reasons to Buy This Report:

Customization:

We provide customization of the study to meet specific requirements:

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact:

Quince Market Insights

Ajay D. (Knowledge Partner)

Office No- A109

Pune, Maharashtra 411028

Phone: US +1 208 405 2835 / UK +44 121 364 6144 / APAC +91 706 672 4848

Email: [emailprotected]

Web: http://www.quincemarketinsights.com

The rest is here:
Blood screening Research, Opportunities, Emerging Trends, Competitive Strategies And Forecasts 2016-2028 - 3rd Watch News

Read More...

Insect Cell Culture MARKET SIZE BY APPLICATION, TYPES, END-USER, REGIONAL ANALYSIS AND FORECAST 2020 TO 2025 – Cole of Duty

June 13th, 2020 12:43 pm

This report additionally covers the effect of COVID-19 on the worldwide market. The pandemic brought about by Coronavirus (COVID-19) has influenced each part of life all inclusive, including the business segment. This has brought along a several changes in economic situations.

New Study about the Insect Cell Culture Market by MRB

The new report offers a powerful combination of latest, in-depth research studies on the Insect Cell Culture market. The authors of the report are highly experienced analysts and possess deep market knowledge.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures): http://marketresearchbazaar.com/requestSample/15998

Major Players Analyzed Under This Report are:

> Life TechnologiesCorning (Cellgro)Sigma-AldrichThermo FisherMerck MilliporeGE HealthcareLonzaBDHiMediaTakaraCellGenixAtlanta BiologicalsPromoCell

Insect Cell Culture Players/Suppliers Profiles and Sales Data: Company, Company Basic Information, Manufacturing Base and Competitors, Product Category, Application and Specification with Sales, Revenue, Price and Gross Margin, Main Business/Business Overview.

Table Of Content

Market Overview: Scope & Product Overview, Classification of Insect Cell Culture by Product Category (Market Size (Sales), Market Share Comparison by Type (Product Category)), Insect Cell Culture Market by Application/End Users (Sales (Volume) and Market Share Comparison by Application), Market by Region (Market Size (Value) Comparison by Region, Status and ProspectInsect Cell Culture Market by Manufacturing Cost Analysis:Key Raw Materials Analysis, Price Trend of Key Raw Materials, Key Suppliers of Raw Materials, Market Concentration Rate of Raw Materials, Proportion of Manufacturing Cost Structure (Raw Materials, Labor Cost), Manufacturing Process Analysis

Key Benefits for Stakeholders

The study provides an in-depth analysis of the Insect Cell Culture market size along with the current trends and future estimations to elucidate the imminent investment pockets.Information about key drivers, restraints, and opportunities and their impact analysis on the market size is provided.Porters five forces analysis illustrates the potency of buyers and suppliers operating in the portable gaming industry.The quantitative analysis of the Insect Cell Culture industry from 2020 to 2026 is provided to determine the Insect Cell Culture market potential.

Insect Cell Culture Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026

The research report is broken down into chapters, which are introduced by the executive summary. Its the introductory part of the chapter, which includes details about global market figures, both historical and estimates. The executive summary also provides a brief about the segments and the reasons for the progress or decline during the forecast period. The insightful research report on the Insect Cell Culture market includes Porters five forces analysis and SWOT analysis to understand the factors impacting consumer and supplier behavior.

Get Customized Report in your Inbox within 24 hours: http://marketresearchbazaar.com/enquiry/15998

Market Segment Analysis

The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type Classical Media & SaltsSerum-free MediaStem Cell Media

Segment by Application Biopharmaceutical ManufacturingTissue Culture & EngineeringGene TherapyCytogenetic

Insect Cell Culture Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

Insect Cell Culture Market: Regional Analysis

The report offers in-depth assessment of the growth and other aspects of the Insect Cell Culture market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2025. These analyses will help the reader to understand the potential worth of investment in a particular region.

Key Strategic Developments:The study also includes the key strategic developments of the Insect Cell Culturemarket, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Key Market Features:The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, market share, CAGR, and gross margin.Analytical Tools: The Insect Cell Culture Market report includes the precisely studied and weighed data of the key industry players and their scope in the Insect Cell Culture market by means of several analytical tools

Read More Report: http://marketresearchbazaar.com/requestSample/15998

About (Market Research Bazaar):

Market Research Bazaar (MRB)- a part of VRRB Reports LLP is an overall Market Research and consulting organization. We give unparalleled nature of offering to our clients present all around the world crosswise over industry verticals. Market Research Bazaar has aptitude in giving profound jump showcase understanding alongside advertise knowledge to our clients spread across over different endeavours.

Media Contact:

Market Research Bazaar

UK: +442070973908

US: +13156360953

India: +919548234540

Email: [emailprotected]

Website: http://marketresearchbazaar.com/

Blog: http://marketresearchbazaar.com/blogs

View post:
Insect Cell Culture MARKET SIZE BY APPLICATION, TYPES, END-USER, REGIONAL ANALYSIS AND FORECAST 2020 TO 2025 - Cole of Duty

Read More...

MUTATIONS IN RAS PATHWAY GENES CORRELATE WITH TYPE OF FAILURE TO AZACITIDINE : GENOMIC ANALYSIS AT RANDOMIZATION ONTO THE INSPIRE TRIAL – SLIDE…

June 13th, 2020 12:43 pm

06/12/2020 | 04:48pm EDT

Abstract #EP829:

Mutations in RAS pathway genes correlate with Type

of Failure to Azacitidine: Genomic Analysis at

Randomization onto the INSPIRE Trial

Koichi Takahashi, MD1, Anna Jonasova, MD, PhD2, Selina M. Luger, MD, FRCPC3, Aref Al-Kali,

MD4, David Valcrcel, MD5, Erica D. Warlick, MD6, Wieslaw W. Jedrzejczak, MD, PhD7, Mara

Dez-Campelo, MD, PhD8, Patrick S. Zbyszewski, MBA9, Christopher Cavanaugh9, Richard C.

Woodman, MD9& Steven M. Fruchtman, MD9, Guillermo Garcia-Manero, MD1

1University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX; 21st Medical Department - Hematology, General Hospital, Prague, Czech Republic; 3Abramson

Cancer Center, University of Pennsylvania, Philadelphia, PA; 4Division of Hematology, Mayo Clinic, Rochester, MN; 5Planta Baixa, Hospital Universitari Vall d'Hebron, Barcelona, Spain; 6Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN; 7MTZ Clinical Research, Medical University of Warsaw, Warsaw, Poland; 8Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain; 9Onconova Therapeutics, Inc., Newtown, PA; 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

EHA May2020

Confidential

1

Introduction

EHA May2020

Confidential

2

Eligibility:

2:1

R

A

Rigosertib + best

N

supportive care

D

N = 240

O

Primary

M

Endpoint:

I

Overall

Z

Survival

A

Physician's Choice of

(288 Events)

T

Treatment + best

I

supportive care

O

N = 120

N

Primary Objective: To compare the overall survival (OS) of patients in the rigosertib group vs PC arm in all patients and a sub-group of patients with IPSS-R very high risk;

Exploratory Objective: Correlation of overall survival and clinical responses with mutational status;

EHA May2020

Confidential

3

Key Inclusion Criteria

EHA May2020

Confidential

4

Methodology

EHA May2020

Confidential

5

Table 1: Patient Demographics (N=190)

Number of patients (%)

Sex

Female

67

(35)

Male

121 (64)

Unknown

2

(1)

Race

Asian

22

(12)

Black

3

(2)

White

152 (80)

Other

6

(3)

Unknown

7

(4)

Age (yr)

Median

73

Range

54 - 82

ECOG performance Status

0

40

(21)

1

87

(46)

2

19

(10)

Read more from the original source:
MUTATIONS IN RAS PATHWAY GENES CORRELATE WITH TYPE OF FAILURE TO AZACITIDINE : GENOMIC ANALYSIS AT RANDOMIZATION ONTO THE INSPIRE TRIAL - SLIDE...

Read More...

(2020-2025) Precision Medicine Software Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,…

June 13th, 2020 12:42 pm

Precision Medicine SoftwareMarket 2020: Inclusive Insight

Los Angeles, United States,June 2020:The report titled Global Precision Medicine Software Market is one of the most comprehensive and important additions to Alexareports archive of market research studies. It offers detailed research and analysis of key aspects of the global Precision Medicine Software market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Precision Medicine Software market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Precision Medicine Software market is carefully analyzed and researched about by the market analysts.

Precision Medicine Software Market competition by top manufacturers/ Key player Profiled: Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42, Inc, Lifeomic Health

Get PDF Sample Copy of the Report to understand the structure of the complete report:(Including Full TOC, List of Tables & Figures, Chart) : https://www.alexareports.com/report-sample/867663

Global Precision Medicine Software Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020- 2025. According to the latest report added to the online repository of Alexareports the Precision Medicine Software market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.

Based on region, the globalPrecision Medicine Software market has been segmented into Americas (North America ((the U.S. and Canada),) and Latin Americas), Europe (Western Europe (Germany, France, Italy, Spain, UK and Rest of Europe) and Eastern Europe), Asia Pacific (Japan, India, China, Australia & South Korea, and Rest of Asia Pacific), and Middle East & Africa (Saudi Arabia, UAE, Kuwait, Qatar, South Africa, and Rest of Middle East & Africa).

Precision Medicine Software Market Segment by Type covers: Cloud-based, On-premise

Precision Medicine Software Market Segment by Industry: Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Others

After reading the Precision Medicine Software market report, readers get insight into:

*Major drivers and restraining factors, opportunities and challenges, and the competitive landscape*New, promising avenues in key regions*New revenue streams for all players in emerging markets*Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions*Demand and uptake patterns in key industries of the Precision Medicine Software market*New research and development projects in new technologies in key regional markets*Changing revenue share and size of key product segments during the forecast period*Technologies and business models with disruptive potential

Key questions answered in the report:

What will the market growth rate of Precision Medicine Software market?What are the key factors driving the global Precision Medicine Software market size?Who are the key manufacturers in Precision Medicine Software market space?What are the market opportunities, market risk and market overview of the Precision Medicine Softwaremarket?What are sales, revenue, and price analysis of top manufacturers of Precision Medicine Software market?Who are the distributors, traders, and dealers of Precision Medicine Software market?What are the Precision Medicine Software market opportunities and threats faced by the vendors in the global Precision Medicine Softwareindustries?What are sales, revenue, and price analysis by types and applications of Precision Medicine Softwaremarket?What are sales, revenue, and price analysis by regions of Precision Medicine Software industries?

Get a discount on this report now at https://www.alexareports.com/check-discount/867663

Table of ContentsSection 1 Precision Medicine Software Product DefinitionSection 2 Global Precision Medicine Software Market Manufacturer Share and Market Overview2.1 Global Manufacturer Precision Medicine Software Shipments2.2 Global Manufacturer Precision Medicine Software Business Revenue2.3 Global Precision Medicine Software Market Overview2.4 COVID-19 Impact on Precision Medicine Software IndustrySection 3 Manufacturer Precision Medicine Software Business Introduction3.1 Syapse Precision Medicine Software Business Introduction3.1.1 Syapse Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.1.2 Syapse Precision Medicine Software Business Distribution by Region3.1.3 Syapse Interview Record3.1.4 Syapse Precision Medicine Software Business Profile3.1.5 Syapse Precision Medicine Software Product Specification3.2 Allscripts Precision Medicine Software Business Introduction3.2.1 Allscripts Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.2.2 Allscripts Precision Medicine Software Business Distribution by Region3.2.3 Interview Record3.2.4 Allscripts Precision Medicine Software Business Overview3.2.5 Allscripts Precision Medicine Software Product Specification3.3 Qiagen Precision Medicine Software Business Introduction3.3.1 Qiagen Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.3.2 Qiagen Precision Medicine Software Business Distribution by Region3.3.3 Interview Record3.3.4 Qiagen Precision Medicine Software Business Overview3.3.5 Qiagen Precision Medicine Software Product Specification3.4 Roper Technologies Precision Medicine Software Business Introduction3.5 Fabric Genomics Precision Medicine Software Business Introduction3.6 Foundation Medicine Precision Medicine Software Business IntroductionSection 4 Global Precision Medicine Software Market Segmentation (Region Level)4.1 North America Country4.1.1 United States Precision Medicine Software Market Size and Price Analysis 2014-20194.1.2 Canada Precision Medicine Software Market Size and Price Analysis 2014-20194.2 South America Country4.2.1 South America Precision Medicine Software Market Size and Price Analysis 2014-20194.3 Asia Country4.3.1 China Precision Medicine Software Market Size and Price Analysis 2014-20194.3.2 Japan Precision Medicine Software Market Size and Price Analysis 2014-20194.3.3 India Precision Medicine Software Market Size and Price Analysis 2014-20194.3.4 Korea Precision Medicine Software Market Size and Price Analysis 2014-20194.4 Europe Country4.4.1 Germany Precision Medicine Software Market Size and Price Analysis 2014-20194.4.2 UK Precision Medicine Software Market Size and Price Analysis 2014-20194.4.3 France Precision Medicine Software Market Size and Price Analysis 2014-20194.4.4 Italy Precision Medicine Software Market Size and Price Analysis 2014-20194.4.5 Europe Precision Medicine Software Market Size and Price Analysis 2014-20194.5 Other Country and Region4.5.1 Middle East Precision Medicine Software Market Size and Price Analysis 2014-20194.5.2 Africa Precision Medicine Software Market Size and Price Analysis 2014-20194.5.3 GCC Precision Medicine Software Market Size and Price Analysis 2014-20194.6 Global Precision Medicine Software Market Segmentation (Region Level) Analysis 2014-20194.7 Global Precision Medicine Software Market Segmentation (Region Level) AnalysisSection 5 Global Precision Medicine Software Market Segmentation (Product Type Level)5.1 Global Precision Medicine Software Market Segmentation (Product Type Level) Market Size 2014-20195.2 Different Precision Medicine Software Product Type Price 2014-20195.3 Global Precision Medicine Software Market Segmentation (Product Type Level) AnalysisSection 6 Global Precision Medicine Software Market Segmentation (Industry Level)6.1 Global Precision Medicine Software Market Segmentation (Industry Level) Market Size 2014-20196.2 Different Industry Price 2014-20196.3 Global Precision Medicine Software Market Segmentation (Industry Level) AnalysisSection 7 Global Precision Medicine Software Market Segmentation (Channel Level)7.1 Global Precision Medicine Software Market Segmentation (Channel Level) Sales Volume and Share 2014-20197.2 Global Precision Medicine Software Market Segmentation (Channel Level) AnalysisSection 8 Precision Medicine Software Market Forecast 2019-20248.1 Precision Medicine Software Segmentation Market Forecast (Region Level)8.2 Precision Medicine Software Segmentation Market Forecast (Product Type Level)8.3 Precision Medicine Software Segmentation Market Forecast (Industry Level)8.4 Precision Medicine Software Segmentation Market Forecast (Channel Level)Section 9 Precision Medicine Software Segmentation Product Type9.1 Cloud-based Product Introduction9.2 On-premise Product IntroductionSection 10 Precision Medicine Software Segmentation Industry10.1 Healthcare Providers Clients10.2 Pharmaceutical and Biotechnology Companies Clients10.3 Research Centers and Government Institutes Clients10.4 Others ClientsSection 11 Precision Medicine Software Cost of Production Analysis11.1 Raw Material Cost Analysis11.2 Technology Cost Analysis11.3 Labor Cost Analysis11.4 Cost OverviewSection 12 Conclusion

Do Inquiry About The Report Here: https://www.alexareports.com/send-an-enquiry/867663

About Us:Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data.

Contact Us:Alexa ReportsPh no: +1-408-844-4624Email: [emailprotected]Site: https://www.alexareports.com

Read this article:
(2020-2025) Precision Medicine Software Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,...

Read More...

Precision Medicine Software Market Breaking New Grounds and Touch new Level in Upcoming Year by Syapse, Allscripts, Qiagen, Roper Technologies, Fabric…

June 13th, 2020 12:42 pm

Precision Medicine Software Market report focused on the comprehensive analysis of current and future prospects of the Precision Medicine Software industry. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the Precision Medicine Software market has been done in order to calculate the growth rates for each segment and sub-segments.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

https://www.a2zmarketresearch.com/sample?reportId=79150

Top Key Vendors of this Market are:

Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42, Lifeomic Health.

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Precision Medicine Software market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Precision Medicine Software markets trajectory between forecast periods.

The report provides insights on the following pointers:

Market Penetration:Comprehensive information on the product portfolios of the top players in the Precision Medicine Software market.

Product Development/Innovation:Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development:Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification:Exhaustive information about new products, untapped geographies, recent developments, and investments in the Precision Medicine Software market.

Hurry Up! Get Upto 25% Discount on this Report @:

https://www.a2zmarketresearch.com/discount?reportId=79150

The report summarized the high revenue that has been generated across locations like, North America, Japan, Europe, Asia, and India along with the facts and figures of Precision Medicine Software market. It focuses on the major points, which are necessary to make positive impacts on the market policies, international transactions, speculation, and supply demand in the global market.

Reasons for buying this report:

Table of Contents

Global Precision Medicine Software Market Research Report 2020 2026

Chapter 1 Precision Medicine Software Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Precision Medicine Software Market Forecast

For more Information, Inquire @:

https://www.a2zmarketresearch.com/enquiry?reportId=79150

If you have any special requirements, please let us know and we will offer you the report as you want.

Read the original here:
Precision Medicine Software Market Breaking New Grounds and Touch new Level in Upcoming Year by Syapse, Allscripts, Qiagen, Roper Technologies, Fabric...

Read More...

Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC – OncLive

June 12th, 2020 3:50 am

Jean Lopategui, MD, discusses the evolution of targeted therapies in nonsmall cell lung cancer.

Jean Lopategui, MD, associate professor of pathology and director of Translational Genomics and of the Molecular Genetics Pathology Fellowship at Cedars-Sinai, discusses the evolution of targeted therapies in nonsmall cell lung cancer (NSCLC).

Ten years ago, not many targeted therapies were available in the field, but there has been a tremendous improvement in the treatment of patients with NSCLC, says Lopategui. The 1-year mortality rate of stage IV NSCLC is about 50%. Today, patients who harbor molecular alterations can experience durable remissions due to the development of targeted therapies.

Additionally, checkpoint inhibitors could be a second-line treatment option after disease progression on targeted therapies or chemotherapy. These agents could further extend the lives of patients with NSCLC. Although these agents are not curative, it is encouraging to see the progress that has been made, concludes Lopategui.

Original post:
Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC - OncLive

Read More...

Renaissance Academy Class of 2020 Graduates with Over $17 Million in Scholarships – MyChesCo

June 12th, 2020 3:50 am

PHOENIXVILLE, PA On Wednesday, June 10th, 2020, seventy-three seniors graduated from the Renaissance Academy Charter School (RA). The ceremony was held at 7:00 pm and included all the RA traditional Commencement Ceremony through video. The event featured Keynote Speaker and Valedictorian speeches, various awards and scholarships presentations, as well as, the seniors being announced and recognized for earning their diplomas

The keynote speaker, selected by student vote, was Kelly Najdawi, the K-12 Curriculum Leader of English Language Arts at RA. Born and raised in Radnor, PA, Mrs. Najdawi graduated Magna Cum Laude from West Chester University in 2008, earning a Bachelor of Science in Education with a Middle School English Language Arts Certification. She began working at RA in 2008.

During her eleven-year career at RA, Mrs. Najdawi taught English Language Arts to this graduating class in both their 7th and 8th grade years. As their teacher, she made a special connection with this class and is confident they will go on to make a real difference in the world. This class has always impressed me with their academic drive, personal voice, and understanding, so I felt they were already best prepared to take on their future. I trust them and the decisions they are going to make and expect them to positively change the status quo by using everything Renaissance has instilled in them.

Also speaking at the ceremony was Carolyn (Carly) Higgins, 2020 Valedictorian. As Carly reflected back on her time at RA, she spoke of the challenges her class faced together as a unified group. She went on to stress the importance of self-dependency and having the bravery to pursue life goals even when there are powerful obstacles ahead. We have the ability to make our dreams a reality, but you have to have the courage to trust yourself first. Thats the world that I want to live in and I know you do too.

In the fall, Carly plans to be on the pre-med track with a dual major in biology and molecular genetics. While she has not yet decided on her specific college, Carly has been accepted to the Rochester Institute of Technologys Physicians Assistant Program (BS/MS) 5 year program, the University of Rochesters biological sciences program in molecular genetics, the University of Richmond; the University of Hawaii at Mnoa, and West Chester University of Pennsylvanias biology-cell and molecular program.

The RA 2020 Salutatorian, Jeremy Wenger, who will be attending Olin College of Engineering located in Needham, Massachusetts, gave his speech during a graduation achievement and awards event on Monday night. Jeremy spoke about the accomplishments and unity of his graduating class, as well as their ability to change the world with what they know is true. Now it is our time to shape the world. We just need to be brave enough to do it.

The Renaissance Academy Charter School graduating class of 2020 includes:Grace Katherine Abendshein (Phoenixville, PA), Jamod O. Adams (Norristown, PA), Mark D. Adams (Royersford, PA), Olivia Elizabeth Andreoni (Eagleville, PA), Joshua David BarrancoSilva (Phoenixville, PA), Daniel Eric Barron (Coatesville, PA), Naomi Michele Bruno (Sanatoga, PA), Gavin Daniel Budniak (West Norriton, PA), Olivia Rose Campbell (Royersford, PA), Giavanna M. Caperila (Phoenixville, PA), Emily Paige Cassidy (Phoenixville, PA), Alyssa N. Cekic (Phoenixville, PA), Brianna Chandler (Norristown, PA), Shaun Maria Chester (Phoenixville, PA), Jahi Peter Clark (Norristown, PA), Gabriel Avery Cole (Pottstown, PA), Geoffrey James Cross Jr. (Pottstown, PA), Emilia Anna Crow (Royersford, PA), Susannah Jeannette Cushmore (Norristown, PA), Cornelius I. Dairo (Norristown, PA), Taylor Lynn Darden (Phoenixville, PA), Gianna Rose Debro (Royersford, PA), Jonathan William DeSanto (Phoenixville, PA), Kayla Nicole Diaz (Norristown, PA), Samuel Miles Dooling (Norristown, PA), Ryan James Dunn (Phoenixville, PA) Olivia Rachel Ferst (Norristown, PA), Nicolette G. Foster (East Norriston, PA), Madison Elizabeth Francis (Pottstown, PA), Avinash Suhas Ganguly (Jeffersonville, PA), Kelly Roberta Garman (Collegeville, PA), Morgan Elizabeth Gidney (Gilbertsville, PA), Jaeshon Goodman-Rhodes (Norristown, PA), Grace Riley Grenier (Jeffersonville, PA), Kathryn Ann Guevin (Phoenixville, PA), Shay S. Gustafson (Collegeville, PA), Kiley Rae Henderson (Pottstown, PA), Carolyn S. Higgins (Morgantown, PA), Kaitlin Bryn Irby (Phoenixville, PA), Majesty Sanai Jerry (Norristown, PA), Jurnee Ann Jessie (Norristown, PA), Adam Christopher Johnson (Norristown, PA), Micaiah Allen Jones (Norristown, PA), Elisabeth Faith Kerper (Jeffersonville, PA), Theresa Rose Kolter (Phoenixville, PA), Malachy L. Lacy (Jeffersonville, PA), Tyler Anthony Magyar (Pottstown, PA), Grace Elizabeth Moreschi (Audubon, PA) Lindsey Nicole ODonnell (Norristown, PA), Max Victor Olstad (Phoenixville, PA), Angelina Clair Pagano (Pottstown, PA), Dominique Xandria Parrish-Hankins (Norristown, PA), James Joseph Pritz IV (East Norriston, PA), Aliyah Nicole Quill (Phoenixville, PA), Benjamin Ali-Reza Rabizadeh (Exton, PA), Erin Kathleen Robbins (Collegeville, PA), Tyler Steven Robbins (Jeffersonville, PA), Trevor Mitchell Schmidt (East Norriton, PA), Lily Catherine Shaffer (Collegeville, PA), Paige Kimberly Simon (Norristown, PA), Lauren R. Stauch (Phoenixville, PA), Sara Bernadette Stockett (Norristown, PA), Lanasha Sweeper (East Norriton, PA), Nathen Lim Te (Norristown, PA), Devon Lynn Testa (Phoenixville, PA), Sarah Irene Trexler (Spring City, PA), Nissi Jayanth Vinnakota (Norristown, PA), Dominique Meghan Vinson (Conshohocken, PA), Alexander Joseph Waskiewicz (Norristown, PA), Cassandra Jean Waskiewicz (Norristown, PA), Jeremy Benjamin Wenger (Royersford, PA), Chandler D. White (Norristown, PA), and Cole Raymond Winters (Phoenixville, PA).

These graduates have been accepted to universities such as Rensselaer Polytechnic Institute, Dickinson College, Boston University, Bucknell University, University of Rochester, Ohio State University, Olin College of Engineering, University of Michigan, American University, George Washington University, and Swarthmore College. They have been collectively offered (to date) a scholarship total of $17,101,514.00, a new Renaissance Academy merit scholarship school record. Tracey Behrens OBrien, RA Academic and College Counselor noted that nearly all of the scholarships have been awarded to the students by the individual universities, not from scholarship search sites. It is so exciting to see an unprecedented number of students in the Class of 2020 being recognized by prestigious colleges.

Due to the current COVID-19 conditions, some of the traditional RA end-of-year senior events were held a little differently. The graduates were celebrated over five unique nights. Each night, a different link was released on the Senior Knights 2020 website. The nights had videos and live feeds with different focuses including a night for athletics and the arts; a senior class photo slideshow night; awards and the Salutatorian speech; the senior parent reveal night; the 2020 commencement ceremony; and finally, the graduates processional parade.

About this special group of graduates, Upper School Principal, Michelle Boyd said, The Class of 2020 will always stand out for all that they have gone through and how they have persevered through such challenging times. The Class of 2o20 displays true grit and determinationthey will surely go on to change the world for the better!

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Originally posted here:
Renaissance Academy Class of 2020 Graduates with Over $17 Million in Scholarships - MyChesCo

Read More...

Ovid Therapeutics Announces Strategic Research Collaboration Focused on Accelerating the Development of New Treatments for Rare Neurological Diseases…

June 12th, 2020 3:50 am

NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc.(NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced a strategic research collaboration with Columbia University Irving Medical Center researchers (Columbia) to advance genetic based therapies for a range of rare neurological conditions, complementary to Ovids current pipeline. This collaboration provides Ovid with the potential to expand its future drug development portfolio and impact individuals living with rare genetic neurological conditions.

Under this research and translational development alliance, Columbia will align its expertise in rare disease genetics and deep clinical understanding of rare neurological diseases with Ovids discovery, translational, and clinical development expertise in neurodevelopmental disorders and rare epilepsies. Ovid will work closely with Wendy K. Chung, M.D., Ph.D., the Chief of Clinical Genetics, and leader of the Precision Medicine Resource in the Irving Institute at Columbia University Irving Medical Center. Dr. Chung is a recognized genetics leader with over 20 years of experience in human genetic research of monogenic and complex traits, mapping and cloning genes in humans, and describing the clinical characteristics and natural history of novel genetic conditions. A 2019 National Organization for Rare Disorders (NORD) Rare Impact Award Honoree, Dr. Chung is also a leader and advocate within the rare disease patient community.

Under the collaboration, Ovid will work together with Columbia scientists to identify molecular targets for developing genetic/molecular therapeutic approaches for rare neurological conditions such as KIF1A-associated neurological disorder (KAND) and other rare conditions.

Ovid has made significant progress in all its late stage clinical programs. We are excited to see multiple read outs of clinical data throughout the year. Its time to begin to build our pipeline for our long-term future in a disciplined and strategic fashion. This next step is built on, and will complement, the important programs we already have in place, said Amit Rakhit, M.D., MBA, President and Chief Medical Officer of Ovid Therapeutics. Joining forces with Columbia and Dr. Chung, a world-class clinical geneticist, will enable Ovid to begin to build a robust gene and molecular therapy platform for the future treatment of inherited neurological conditions.

My laboratory is committed to discovering innovative new targets and therapies to address rare neurological diseases with few or no treatment options, said Dr. Chung. This alliance is further evidence of Columbias unwavering commitment to enabling groundbreaking research and developing cutting-edge technologies to treat neurological conditions. We are excited to partner with Ovid and the patient community to help advance these programs into clinical trials for development of new potential therapies.

About Ovid TherapeuticsOvid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines. The Companys most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 (soticlestat) in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE). For more information on Ovid, please visit http://www.ovidrx.com/.

Forward-Looking Statements This press release includes certain disclosures that contain forward-looking statements, including, without limitation, statements regarding: advancing and commercializing Ovids product candidates, progress, timing, scope and thedevelopment andpotential benefitsofOvids product candidates; and the anticipated reporting schedule of clinical data regarding Ovids product candidates. You can identify forward-looking statements because they contain words such as will,appears,believes and expects. Forward-looking statements are based on Ovids current expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements includeuncertainties in the development and regulatory approval processes,andthe fact that initial data from clinical trials may not be indicative, and are not guarantees, of the final results of the clinical trials and are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and/or more patient data become available. Additional risks that could cause actual results to differ materially from those in the forward-looking statements are set forth in Ovids filings with theSecurities and Exchange Commissionunder the caption Risk Factors.Such risks may be amplified by the COVID-19 pandemicand its potential impact on Ovids businessand theglobal economy.Ovid assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

Contacts

Investors and Media:Ovid Therapeutics Inc.Investor Relations & Public Relationsirpr@ovidrx.com

Or

Investors: Steve KlassBurns McClellan, Inc.sklass@burnsmc.com (212) 213-0006

Media:Katie Engleman1ABkatie@1abmedia.com(919) 333-7722

Link:
Ovid Therapeutics Announces Strategic Research Collaboration Focused on Accelerating the Development of New Treatments for Rare Neurological Diseases...

Read More...

Outlook on the United States Solid Tumor Testing Industry to 2030 – Analysis and Forecast – GlobeNewswire

June 12th, 2020 3:50 am

Dublin, June 08, 2020 (GLOBE NEWSWIRE) -- The "U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Biomarker Type, Application, End User, State Region, and Competitive Landscape - Analysis and Forecast, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

According to this market intelligence report titled the U.S. solid tumor testing market was valued at $8,179.7 million in 2019 and is anticipated to grow over $15,396.4 million by 2030. The U.S. solid tumor testing market is expected to grow at a single-digit compound annual growth rate in the forecast period 2020-2030, aided primarily by the high growth in the molecular diagnostics market.

The term solid tumor refers to abnormal cellular growths, which generally comprise sarcomas, carcinomas, and lymphomas. The current solid tumor testing market is mainly dominated by several diagnostic majors, such as Quest Diagnostics Incorporated, Laboratory Corporation of America, Foundation Medicine, which offer a wide variety of testing services for solid tumors. These testing services range from molecular-genetic tests to liquid biopsies for the confirmatory diagnosis of solid tumors. The key players in the product segment include Illumina, Abbott Laboratories, and ThermoFisher Scientific, which offer kits for the analysis of solid tumors.

The solid tumor tests are generally based on technologies such as fluorescence in situ hybridization (FISH), immunohistochemistry (INC), bi-directional sanger sequencing, polymerase chain reaction (PCR), next-generation sequencing (NGS), and other technologies. The underlying utility of diagnostic testing for solid tumors is based on the identification of clinically actionable gene mutations, which provide crucial information on diagnosis, prognosis, and theranosis of solid tumors and thereby facilitate clinical work-up, treatment management, and therapeutic selection.

The existing market of solid tumor testing is favored by multiple factors, which include rising government initiatives, increasing incidence of cancer, thereby increasing the utilization of testing technologies to identify the underlying mutations. In addition, an increasing number of product approvals and launches pertaining to U.S. solid tumor testing market will provide a lucrative growth for this market. Moreover, increasing the use of biomarkers in cancer profiling is also one of the key driving factors for the solid tumor testing market.

Government funding is also one of the major growth factors for the solid tumor testing market because increasing funding by the government is expected to facilitate research institutes and key players to develop as well as market novel assays useful for the diagnosis of several tumors. Increasing funding will lead to the liquidity of the solid tumor market, and thus, companies will develop various testing options for solid tumors to identify the underlying mutations that serve as a possible cause for the disease. All these factors are therefore expected to contribute to the market growth during the forecast period.

Within the research report, the market is segmented on the basis of product type, technology, application, end user, cancer type, biomarker type, and region, which highlight value propositions and business models useful for industry leaders and stakeholders. The research also comprises state-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360-degree coverage of the domain.

This report is a meticulous compilation of research on more than 30 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants, and vendors. The report also comprises 15 detailed company profiles including several key players, such as Abbott Laboratories, Laboratory Corporation of America, Quest Diagnostics Incorporated, Illumina, F. Hoffmann-La Roche, ARUP Laboratories, Bio-Rad Laboratories, Inc., Asuragen Inc., Cancer Genetics Inc., Invitae Corporation, NeoGenomics Laboratories, Inc., and QIAGEN N.V.

Key trends targeted in the report:

Key Topics Covered:

1 Product Definition1.1 Inclusion and Exclusion

2 Market Scope2.1 Scope of Work2.2 Key Questions Answered in the Report

3 Research Methodology3.1 U.S. Solid Tumors Testing Market: Research Methodology3.2 Data Sources3.3 Secondary Data Sources3.4 Market Estimation Model3.5 Criteria for Company Profiling

4 Market Overview4.1 Definition4.2 Solid Tumor Testing Technologies4.3 Market Size and Growth Potential, $Million, 2019-20304.4 Industry Participants Landscape

5 Epidemiology of Solid Tumors in U.S.

6 Industry Insights6.1 Regulation of Genetic Tests6.1.1 FDA Regulation6.1.2 CMS Regulation6.2 Reimbursement Scenario6.2.1 Impact on Laboratory Industry

7 Market Dynamics7.1 Market Drivers7.1.1 Rising Incidence of Cancers7.1.2 Decreasing Cost of Sequencing7.1.3 Increasing Adoption of Inorganic Growth Strategies in the Market7.1.4 Increasing Research Funding from the National Cancer Institute7.1.5 Expected Increase in Adoption of Genetic Testing7.2 Restraints7.2.1 Reimbursement Cuts in the U.S.7.2.2 Expected Implementation of the Patient Protection and Affordable Care Act in the U.S.7.2.3 High Pricing Pressure7.3 U.S. Market Opportunities7.3.1 Informatics and Technological Innovation for Larger Consumer Base7.3.2 Mushrooming Direct-to-Consumer (DTC) Testing Services Market

8 Competitive Landscape8.1 Key Strategies and Developments8.1.1 Synergistic Activities8.1.2 Approvals8.1.3 Product Launches, Enhancements, and Expansion8.1.4 Acquisitions and Mergers8.2 Product Scenario8.3 Funding Scenario8.4 Market Share Analysis8.5 Growth Share Analysis (Opportunity Mapping)8.5.1 By Company8.5.2 By Technology8.5.3 By Application8.5.4 By Cancer Type

9 U.S. Solid Tumor Testing Market (by Technology)9.1 Overview9.2 Next-Generation Sequencing9.3 In Situ Hybridization9.4 Polymerase Chain Reaction9.5 Immunohistochemistry9.6 Other Technologies

10 U.S. Solid Tumor Testing Market (by Cancer Type)10.1 Overview10.2 Breast Cancer10.3 Prostate Cancer10.4 Colorectal Cancer10.5 Lung Cancer10.6 Melanoma10.7 Endometrial Cancer10.8 Thyroid Cancer10.9 Brain Cancer10.10 Ovarian Cancer10.11 Liver Cancer10.12 Other Cancer Types

11 U.S. Solid Tumor Testing Market (by Type of Biomarker)11.1 Overview11.2 Genetic Biomarkers11.3 Protein Biomarkers11.4 Other Biomarkers

12 U.S. Solid Tumor Testing Market (by Application)12.1 Overview12.2 Clinical12.3 Research

13 U.S. Solid Tumor Testing Market (by End User)13.1 Overview13.2 Hospitals, Diagnostic Laboratories, and Reference Laboratories13.3 Pharmaceutical and Biotechnology Companies13.4 Contract Research Organizations13.5 Academic Research Institutions13.6 Other End Users

14 U.S. Solid Tumor Testing Market (by State Region)14.1 Overview14.2 The South U.S.14.3 The Midwest U.S.14.4 The Mid-Atlantic U.S.14.5 The West U.S.14.6 The Southwest U.S.14.7 New England

15 Company Profiles15.1 Overview15.2 Abbott Laboratories15.2.1 Company Overview15.2.2 Role of Abbott Laboratories in the U.S. Solid Tumor Testing Market15.2.3 Financials15.2.4 Key Insights About Financial Health of the Company15.2.5 SWOT Analysis15.3 Illumina, Inc.15.4 F. Hoffmann-La Roche Ltd.15.5 Bio-Rad Laboratories, Inc.15.6 ASURAGEN, INC.15.7 Cancer Genetics Inc.15.8 QIAGEN N.V.*15.9 Quest Diagnostics Incorporated15.10 ARUP Laboratories15.11 Invivoscribe, Inc.15.12 NeoGenomics Laboratories, Inc.15.13 Invitae Corporation15.14 Opko Health15.15 Laboratory Corporation of America Holdings15.16 OmniSeq15.17 Nanostring Technologies15.18 Guardant Health15.19 Personal Genome Diagnostics15.20 HTG Molecular Diagnostics15.21 Caris Life Sciences15.22 Genomic Testing Cooperative15.23 ArcherDX, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/wer8j9

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Continue reading here:
Outlook on the United States Solid Tumor Testing Industry to 2030 - Analysis and Forecast - GlobeNewswire

Read More...

Exercise Alters Molecules In The Blood – Anti Aging News

June 12th, 2020 3:50 am

According to a recent study published in PubMed a single session of exercise alters 9,815 of the 17,662 different molecules in our blood that were measured in this study, with the types of molecules widely ranging and some being involved in fueling, metabolism, immune responses, tissue repair, or appetite. Within those categories the molecular courses changed within an hour with those that increase inflammation surging early than dropping to be replaced with those more likely to help reduce inflammation.

It was like a symphony, says Michael Snyder, the chair of the genetics department at Stanford University and senior author of the study. First you have the brass section coming in, then the strings, then all the sections joining in.

This study is suggested to be the most comprehensive catalog to date of the molecular changes that occur during and after exercise that highlights how consequential activity/inactivity may be for the human body and health.

Different peoples blood follows different orchestrations; those showing signs of insulin resistance for example tended to show smaller increases in some of the molecules related to healthy blood sugar control and higher increases in molecules involved in inflammation, suggesting that they may be somewhat resistant to the general beneficial effects of exercise. Additionally, depending on the individuals current aerobic fitness levels of other molecules ranged considerably.

Overall the researchers were surprised by their findings regarding what they were observing in the changes in molecular profiles after exercise: I had thought, its only about nine minutes of exercise, how much is going to change? A lot, as it turns out. said Dr. Snyder.

However, this study was not without its limitations such as being a small study that only included participants over the age of 40, and it only looked at a single session of aerobic exercise, as such this study cant tell us anything about the longer term molecular effects of continued training or of how the changes in molecular levels may subsequently alter health.

The research team will be conducting follow up studies with more participants and sustained exercise routines, hoping to establish whether certain molecular responses to exercise may be able to distinguish those who might benefit from emphasizing resistance exercises over endurance training, and whether specific molecular profiles can indicate who has higher/lower aerobic endurance. Such answers may provide information that could allow physicians and researchers alike to check for fitness with a blood sample rather than treadmill stress testing.

See the original post here:
Exercise Alters Molecules In The Blood - Anti Aging News

Read More...

GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET (COVID 19 UPDATE )Overview by Type, Technological Advancements & Forecast to 2027 – Medic…

June 12th, 2020 3:50 am

The GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET report gives information about the competitive situation among the market vendors and company profile, besides this, the report also provides market price analysis and value chain features. The scope of this industry report includes in-depth insights of global and regional markets with the sense given for variation in the growth of the ABC industry in certain regions. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET research report offers information on production development, market sales, regional trade, investment calculation, investment opportunity, trade outlook, policy, regional market and other important characteristic of the wire and cable market.

A comprehensiveGlobal Point of Care Molecular Diagnostics Marketanalysis report serves to be an ideal solution for better understanding of the market and high business growth. It has become the requisite of this rapidly changing market place to take up such marker report that makes aware about the market conditions around. This market report comprises of an array of factors that have an influence on the market and industry which are industry insight and critical success factors (CSFs), market segmentation and value chain analysis, industry dynamics, drivers, restraints, key opportunities, technology and application outlook, country-level and regional analysis, competitive landscape, company market share analysis and key company profiles.

Market Analysis:

TheGlobal Point of Care Molecular Diagnostics Marketis estimated to rise from the value of USD 627.6 million in 2017 to an estimated value of USD 1933.2 million by 2025, registering a CAGR of 15.1% during the forecast period of 2018-2025. This growth can be attributed to the rising cases of infectious diseases, and the growing demand for approved Point of Care Molecular Diagnostic tests.

Key Market Competitors:Few of the major competitors currently working on the Point of Care Molecular Diagnostics Market are Agilent Technologies Inc., Abbott, F. Hoffmann-La Roche Ltd., Illumina Inc., Hologic Inc., QIAGEN, Myriad Genetics, Cepheid, Genomic Health, GenePOC Inc., DxNA LLC., Binx Health Inc., Spartan Bioscience Inc., Biocartis, Beckman Coulter Inc., Johnson & Johnson Services Inc., Medtronic, Siemens Healthcare GmbH, Grifols S.A., Abaxis, Bayer AG, bioMrieux SA, Bio-Rad Laboratories Inc., Danaher, OraSure Technologies Inc., BD, Sysmex Corporation, Quidel Corporation, and Meridian Bioscience Inc.

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-molecular-diagnostics-market

Global Point of Care Molecular Diagnostics Market,By Product (Assays & Kits, Instruments/Analyzers, Services & Software), Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-acquired Infection, Oncology, Hepatitis, Others), Technology (Polymerase Chain Reaction, In-Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification, Others), End-User (Physician Offices, Hospitals, Research Institutes, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa) Industry Trends & Forecast to 2025

Competitive Analysis:

The Global Point of Care Molecular Diagnostics Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Point of Care Molecular Diagnostics market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Market Definition:Global Point of Care Molecular Diagnostics Market

Point of Care Molecular Diagnostics is diagnostic equipment which is used to determine the cause of infectious disease causing agents. These machines/equipments help determine the accurate cause of these diseases in a timely manner, which is of utmost importance when dealing with these kind of diseases and also to implement the correct course of action.

The advancements and developments in the diagnostics market is attributed to the fact that the healthcare industry is focusing on detection and diagnosis in place of pharmaceuticals and medicines, to prevent the development of the diseases. This trend has directly affected the market growth and is helping the market to grow significantly.

North America had the highest revenue share of around 40% of the market.

Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-point-of-care-molecular-diagnostics-market

Market Drivers:

Market Restraints:

Segmentation:Global Point of Care Molecular Diagnostics Market

Key Developments in the Market:Global Point of Care Molecular Diagnostics Market

Key Insights in the report:

Market Segmentation:-

To comprehend Global Point of Care Molecular Diagnostics market dynamics in the world mainly, the worldwide Point of Care Molecular Diagnostics market is analyzed across major global regions.

Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.

Some of the Major Highlights of TOC covers:

Chapter 1: Methodology & Scope

Definition and forecast parameters

Methodology and forecast parameters

Data Sources

Chapter 2: Executive Summary

Business trends

Regional trends

Product trends

End-use trends

Chapter 3: Industry Insights

Industry segmentation

Industry landscape

Vendor matrix

Technological and innovation landscape

For More Insights Get Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-point-of-care-molecular-diagnostics-market

Point of Care Molecular Diagnostics Market report effectively provides required features of the global market for the population and for the business looking people for mergers & acquisitions, making investments, new vendors or concerned in searching for the appreciated global market research facilities. It offers sample on the size, offer, and development rate of the market. The Point of Care Molecular Diagnostics report provides the complete structure and fundamental overview of the industry market.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Researchset forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:[emailprotected]

See the rest here:
GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET (COVID 19 UPDATE )Overview by Type, Technological Advancements & Forecast to 2027 - Medic...

Read More...

Genetron Health Strengthens Partnership with Thermo Fisher Scientific to Expand Precision Cancer Diagnosis and Monitoring Across China’s Public…

June 12th, 2020 3:50 am

BEIJING--(BUSINESS WIRE)-- Genetron Holdings Limited (Genetron Health), a China-based precision oncology company that covers full-cycle cancer care, has entered into a strategic partnership agreement with Thermo Fisher Scientific (Thermo Fisher). With plans to build on the sequencer Genetron S5 (Registration Number 20193220820), the partnership aims to enhance innovation, commercialization and promotion of next-generation sequencing (NGS) platforms in the field of molecular cancer diagnosis in Chinas public hospitals.

The partnership will introduce the Companys medium-throughput NGS system Genetron S5 to public hospitals across China, promoting the application and development of Genetron S5 in more fields, such as reproductive health, genetic disease, pathological microorganism testing, and other independent clinical lab testing and scientific research.

Genetron Health is committed to leading and empowering the cancer diagnostics and treatment industry, said Wang Sizhen, Co-Founder and CEO of Genetron Health. We have been working with Thermo Fisher, one of our world-class partners, to create open, flexible, convenient and accurate molecular diagnostic products, and to offer a comprehensive one-stop solution. Our products and solutions are designed to empower medical institutions continuously improve their diagnostic and treatment capabilities, bringing more accurate and speedy services to the public.

Thermo Fishers memorandum of understanding with Genetron in this field will help further our companies work together to develop IVD solutions for the fast-growing Chinese market, said Tony Acciarito, president of Thermo Fisher Scientific China We look forward to generating significant customer value and promoting precision medicine to improve public health throughout China.

Genetron Health has received National Medical Products Administration (NMPA) approval for clinical application of seven IVD products, which cover three major technology platforms: the NGS, dPCR and qPCR. The NGS platform, in particular, provides flexible combinations of products with low, medium and high-throughput. Genetron Health also offers overall R&D and commercialization solutions for in vitro diagnostic technologies available on multiple technology platforms and in various application scenarios, by fully exploring and tapping into the unique strength of each technology platform.

About Genetron S5

Genetron S5 platform approved by NMPA on November 1, 2019, is a medium-throughput NGS system that enables simple targeted sequencing workflows at an affordable price, without compromising on performance or reliability. Genetron S5 platform offers several throughput options, which provide the flexibility to scale from small to large projects, enabling multiple targeted sequencing applications on a single system. Based on the design, Genetron S5 is particularly suitable for hospitals as it offers more practical solutions and greater scalability.

About Genetron Health

Genetron Health a leading and fast-growing precision oncology company in China that aims to provide one-stop genomic profiling solutions for multiple scenarios covering early screening, diagnosis and monitoring, and biopharmaceutical services. The company collaborates with over 500 hospitals and dozens of biopharmaceutical companies and research institutions, and has developed a large proprietary genomic database.

Genetron Health has established R&D centers in both the United States and China, two manufacturing facilities with both ISO 13485:2016 certification and ISO 9001 2015 certification in China and five clinical laboratories in Beijing (CLIA accreditation and CAP certification), Shanghai, Hangzhou, Chongqing and Guangzhou. The R&D capacities of Genetron Health are supported by a best-in-class research and development team led by scientists at the forefront of cancer genomics research. The company has published many research papers in highly influential worldwide peer-reviewed scientific journals, such as Nature Genetics, Nature Communications, Cell Research and PNAS. For more information, please visit http://www.genetronhealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200610005920/en/

See the original post:
Genetron Health Strengthens Partnership with Thermo Fisher Scientific to Expand Precision Cancer Diagnosis and Monitoring Across China's Public...

Read More...

DNA unlocks the secrets of the Dead Sea Scrolls – Haaretz

June 12th, 2020 3:50 am

Over 70 years ago, a Bedouin shepherd named Muhammed ed-Dib entered a cave in the Qumran area west of the Dead Sea. In it he found large clay jars containing parchment scrolls wrapped in linen. Ed-Dib didnt know it, but he had stumbled upon the first pieces of one of the most important archaeological discoveries of the 20th century, which would come to be known as the Dead Sea Scrolls. The scrolls opened a window to the spiritual world and quotidian life of the Second Temple period one of the most tempestuous eras in Jewish history and shed light on the process by which various Jewish sects sprang up during that time, one of which would morph into Christianity. But even today these archaeological finds continue to raise more questions than answers.

A major reason for the contentious disputes is that the collection of scrolls in Israel today consists of nearly 25,000 fragments of parchment and papyrus (the lions share of all the known scroll artifacts in the world) which, it is estimated, come from more than 930 different ancient manuscripts. This vast jigsaw puzzle, with an unknown number of pieces that have been lost over time, includes the earliest versions found to date of all the books of the Hebrew Bible (with the exception of the Book of Esther), as well as the biblical apocrypha and many other works previously unknown.

The conventional theory is that some of those works were written or copied by a zealous Jewish sect, identified by most scholars as the Essenes, who led an ascetic life in the desert. However, there is now general agreement that the collection also includes scrolls that originated from outside the sect, written by other learned individuals of that period. Accordingly, the question of which texts are unique to the sect and which were brought in from outside is crucial for understanding the significance of the texts, and to what extent they represent the ideas in currency in Judea of the latter Second Temple period (334 B.C.E.-70 C.E.). A study published this week as the cover story of the scientific journal Cell has harnessed the most advanced tools of biological research in order to help solve the mystery.

The study was conducted by researchers from Tel Aviv University, led by Prof. Oded Rechavi, from the George S. Wise Faculty of Life Sciences and the Sagol School of Neuroscience, and Prof. Noam Mizrahi from the department of biblical studies, in collaboration with Prof. Mattias Jakobsson of Uppsala University in Sweden, the Israel Antiquities Authority, Prof. Dorothee Huchon-Pupko from TAUs zoology department, and Prof. Christopher E. Mason of Weill Cornell Medicine.

Using techniques of DNA sequencing and sophisticated methods of computation, the scientists were able to identify and catalog 26 parchment fragments (plus another 13 leather artifacts) according to the DNA of the animals on whose skins the scrolls were written, and thus to determine which fragments are related to one another, and which ones not.

There are many scrolls fragments that we dont know how to connect, and if we connect wrong pieces together it can change dramatically the interpretation of any scroll, says Prof. Rechavi. Assuming that fragments that come from the same sheep belong to the same scroll, it is like piecing together parts of a puzzle.

The methods the researchers employed have already helped to shed light on a host of important historical and religious issues: how the concept of sacredness in regard to the texts of biblical books changed over time; when basic notions arose in the realm of Jewish mysticism from which the kabbala sprang; and what the origin was of the idea that prayer could replace sacrificial offerings an idea that was formerly thought to have emerged only following the destruction of the Second Temple, in 70 C.E.

But before applying themselves to matters of remote Jewish history, the researchers had first to overcome a series of challenges, starting with how to collect the sensitive samples. In most cases, to avoid damage to the priceless antiquities, the researchers extracted DNA from tiny scroll crumbs (dust) that fell off, or were scraped off the backs of the fragments. The researchers even demonstrated that they could retrieve authentic ancient DNA from adhesive tape used in the 1950s to piece fragments together that was removed from scrolls.

We were not even allowed to touch the scrolls, says Dr. Sarit Anava, from Rechavis laboratory at TAU. The solution, she explains, was for the Israel Antiquities Authority, which stores all of the scroll pieces in its laboratories at the Israel Museum, to place the samples in test tubes, which she took to Sweden to the laboratory of geneticist Mattias Jakobsson at Uppsala University, which was specially adapted to enable the isolation of ancient genetic materials. In this way, a scroll-crumb is transformed into a window onto Jewish history.

Weve thought for years that the scrolls DNA should be examined, says Prof. Jonathan Ben-Dov, an expert on the Dead Sea Scrolls from the University of Haifas department of Jewish history and biblical studies. Everyone waited for it to happen, and it finally succeeded, adds Ben-Dov, who was not involved in the new study.

If so, what has been discovered?

Comparing texts

The first insight divined by the researchers related to the way inhabitants of Judea in the Second Temple period viewed the texts of the Bible. Apparently, the Judaism of that era didnt have one standard version of each of the sacred texts; in other words, not every jot and tittle in the Bible was regarded with the same holiness it would later possess. The scholars reached this conclusion by examining four fragments of parchment containing sections from the Book of Jeremiah.

Today all editions of the Hebrew Bible are absolutely identical, down to the letter. This was the case even before the invention of printing, in fact since the emergence of the authoritative Masoretic Text of the Bible in Tiberias in the early Middle Ages a version that has been preserved almost without alteration to this day. However, other, even-older versions of the Scriptures also exist, notably the Septuagint. This Greek translation of the Hebrew Bible, originating in Alexandria and dating to the third and second centuries B.C.E., was eventually adopted by the Greek Orthodox Church and remains in use today. The differences between the Masoretic Text and the Septuagint are especially striking in Jeremiah.

Its not a matter of the interchange of a letter here and there, or differences between a few isolated words, says Noam Mizrahi, the biblical scholar. The Septuagint text of Jeremiah is 15 percent shorter than the long version reflected in the Masoretic Text. Furthermore, the two texts differ in the way their sections are arranged; in some of the prophecies there are differences in the order and in the content of the verses. The result is, in effect, completely different editions of the prophetic text, and at times entirely different texts.

Differences of this sort in the books of the Hebrew Bible disappeared in the wake of the destruction of the Temple.

What remained are smaller differences at the orthographical level, which persisted into the Middle Ages because the books were copied by hand, Mizrahi continues. In late antiquity and the Middle Ages, rigorous mechanisms of quality control were applied, which ensured that the differences would hardly ever affect an understanding of the content.

Which versions of Jeremiah appear on the scroll fragments examined by the research team? One fragment contains a long version close the Masoretic text, two contain a short version that resembles the Septuagint, and a fourth has a different, independent text.

Mizrahi: There was a scholarly debate over three of these segments, about whether they originally belonged to the same scroll or came from different scrolls, because they look very similar to each other but differ in the handwriting of the copyist.

Enter genetic classification: The scientists discovered that the vast majority of scroll pieces they examined were written on the skin of sheep an animal that could also be bred in the climatic conditions of the Judean Desert 2,000 years ago. The fragments of the Book of Jeremiah that stirred debate, however, were written on the skins of two different animals: two on sheep and two on the skin of a cow, an animal that was not ordinarily raised in the Judean Desert.

For the scientists, discovery of which animal skin was used for copying the texts represents a significant, genetic confirmation of the hypothesis that the writing was not solely the work of the desert sect but of someone from the outside.

Cow-skin scrolls were manifestly not produced there, but originated externally, Mizrahi says. And while theoretically they might have been brought to Qumran as blank parchments, such a scenario makes very little sense from a practical and economic point of view, so it seems they were brought already as written manuscripts. The conclusion that these are two separate versions of Jeremiah neither of which, apparently, was copied by the local sect, but rather originated in a different context and place, points to the possibility that an openness to divergent texts of the Holy Scriptures reflects a more general approach in Judea at that time.

He adds, As long as there was only the Greek translation, it could be argued that [the existence of different versions could be attributed to] the Diaspora [the Jews of Alexandria]. But the scrolls indicate that the multiplicity of versions was a basic feature of Judaism as a whole, during that period, and particularly in Judea.

According to Prof. Michael Segal an expert in the Dead Sea Scrolls and the dean of humanities at the Hebrew University of Jerusalem the new findings are consistent with a current theory that holds that some of the scrolls came from outside Qumran. One reason is that some of them antedate the founding of the community itself, notes Segal, who was not involved in the current study. To which Jonathan Ben-Dov adds, We have been playing with theories about the biblical text for hundreds of years. Now, thanks to biology, we have an Archimedes fulcrum, with whose aid we can examine those theories.

Heavenly temple

One of the greatest challenges of DNA research is to locate genetic material of sufficiently high quality to enable laboratory analysis. According to Prof. Yitzhak Pilpel, head of the molecular genetics department of the Weizmann Institute of Science in Rehovot, who was not involved in the study, this is particularly true in cases of genetic samples that need to be extracted from the most minuscule fragments of ancient relics. To overcome this obstacle, scientists involved in the new research used a variety of methods that enabled them to examine the surviving ancient genetic material at different resolutions. For example, the species of animal from which the scrolls were fashioned sheep or cow was identified by comparing sections of the mitochondrial DNA found in the cells of the parchment skin to that of more than 10 species of animals until a match was found. Other methods allowed the scientists to determine the genetic relationship between the different sheep whose skins were used in creating the scrolls.

The second method analyzing the basic genetic groups (haplogroups) of the sheep made it possible for the researchers to derive insight concerning Songs of the Sabbath Sacrifice, one of the most intriguing and important texts found in the Qumran scrolls.

This is a composition that was unknown before the discovery of the scrolls, but 10 copies of it were found among the scrolls themselves clear evidence of its importance, Prof. Mizrahi explains. What was not clear was whether the importance of Songs of the Sabbath Sacrifice was unique to the sectarian group that left the scrolls behind, or whether it represents the works popularity among a broader community.

One reason for the considerable interest in this composition is that one copy of the Songs was found 55 kilometers south of the Qumran caves, in the excavations on Mt. Masada. Many scholars had discerned a connection between the discoveries at both sites. In their view, during the Great Revolt of 66-70 C.E, when the Romans who ruled the country were preparing to lay siege to Jerusalem, and the Qumran community was annihilated the sects survivors fled and joined the Jewish rebels who had barricaded themselves at Masada.

The new study calls this hypothesis into question, at least as far as the textual evidence is concerned. A comparison of the DNA of the sheep showed that the scrolls found at Qumran were all made from animals belonging to one genetic population group, whereas the scroll found at Masada was made from the skin of a sheep from a different group.

We did not expect that result, Mizrahi admits. It shows that it is unlikely that this copy of the Songs was brought to Masada by a refugee from Qumran, because this scroll differs biologically, materially, from the scrolls found at Qumran.

According to Ben-Dov, the new biological information thats come to light does not rule out a connection between the sites. After all, the study itself showed that at Qumran there were scrolls made from the skin of different animals, such as cows, he says. Still, he adds, the findings reinforce the possibility that the Masada scroll is not directly connected to Qumran. This possibility that this religious work was widely circulated in the Judea at that time, outside the sect has significant implications for understanding the spiritual life of Second Temple Judea.

Mizrahi adds that discovering the source of the copies of Songs of the Sabbath Sacrifice is particularly important, because of the uniqueness of the text. It is a liturgical composition a collection of Sabbath prayers but also contains an internal narrative. It describes the heavenly temple and the angels rite of worship. It can be inferred, then, that the authors and readers of the text assumed that there is in heaven a temple parallel to the earthly one and that angel-priests in it are engaged in worship. However, activity in the heavenly temple did not center around offering sacrifices as was true in the Jerusalem Temple, but focused on nonstop uttering of praises of God.

Why is this important? This was a period when the Temple was still operating, Mizrahi explains. The conventional view of researchers until a generation ago was that the idea of fixed and statutory prayer replacing sacrificial offerings in the Temple emerged in Judaism only after the destruction of the Second Temple. Accordingly, at the dawn of Qumran studies, the approach that derived from analysis of the Dead Sea Scrolls and the discovery of the prayer collections they contain, was that the Judean Desert sect predated Judaisms transition from sacrificial rituals to the practice of prayer. Scholars in the past explained that the disputes between different sects of the Second Temple period sects, and the insistence of one of them on particularly strict rules of ritual purification led to the latter keeping their distance from the Jerusalem Temple and remaining secluded in the desert hence their development of the idea of prayers as a substitute.

However, Mizrahi says now, this hypothesis needs to be reconsidered in light of the discovery that the Masada copy of Songs of the Sabbath Sacrifice is not genetically linked to the Qumran copies.

It turns out that the idea of prayer as the center of worship was popular beyond Qumran. Were these other communities of the [same] sect that lived in other places? Possibly, he says, referring to a theory that offshoots of the main sect were active elsewhere. But now we know that the centrality of prayer in the worship of God was not unique to Qumran.

Beyond this, there are additional distinctive features of the Songs of the Sabbath Sacrifice, among them elements that would surface centuries later in early Jewish mystical writings known as Hekhalot and Merkhavah (literally, the Heavenly Palaces and the Divine Chariot-Throne) literature. This is a collection of mystical compositions of which the earliest manuscripts were found in the Cairo Genizah. Scholars are divided about the dating of the original works, but its conventionally thought that they were written in the second half of the first millennium C.E.

Says Mizrahi: This is the oldest layer of Jewish mystical literature, and the foundation on which other mystical doctrines were built, including what would subsequently feed the kabbala literature.

For example, the concept of the chariot of God, which first appears in Ezekiel, develops in the Songs of the Sabbath Sacrifice and hundreds of years later in the Hekhalot literature into the idea that the believer can, through a spiritual journey, be elevated to the heavenly temple, enter the Holy of Holies and see Gods chariot. For 30 years, scholars have been arguing about the nature of the connection between the Songs of the Sabbath Sacrifice and the mystical literature that appeared later.

Over the years, the discovery of this text and the fact that it was attributed to the Qumran community contributed to cultivating the notion that the sect served as a source of inspiration for ideas that later informed Jewish and Christian mysticism. The problem was that until now, no one knew exactly how the transition came about.

As long as Songs of the Sabbath Sacrifice was perceived as a work unique to Qumran, there was a missing link between Qumran and the whole mystical tradition that develops in late antiquity, the early Middle Ages and afterward, Mizrahi says. But if we know now that Songs of the Sabbath Sacrifice was a work that was known outside Qumran and until now there was no clear sign of that then we can understand that there were other channels of transmission of these texts and ideas that bridge the missing link.

Scroll clusters

Another significant achievement of the new genetic study is to reinforce one of the leading methods today for classifying the Dead Sea Scrolls, which until now was based on an analysis of the way they were written. For this purpose, the scientists analyzed sheep sequence variation in the nuclear genome, by means of deep DNA sequencing and algorithms developed by Moran Neuhof, Dr. Hila Gingold and Or Sagy from Prof. Rechavis laboratory. These comparisons enabled them to distinguish between a cluster of scrolls made from sheep bearing high genetic similarities, and scrolls made from sheep that do not belong to this cluster and that are also genetically remote from one another.

This time the researchers applied DNA analysis to the nuclear sheep genome (rather than the mitochondrial genome, which doesnt allow distinguishing between individual sheep), to evaluate the system of classification proposed by Prof. Emanuel Tov, who was editor-in-chief of the international Dead Sea Scrolls Publication Project. The Bible scholar classified the findings into two groups according to 20 scribal signs, such as how the authors of the scrolls inserted corrections, spelled words, marked the explicit name of God (the Tetragrammaton) and so on. According to this classification method, presented in a series of publications, principally during the 1930s, the overwhelming majority of the texts possessing a content unique to the members of the Qumran sect match one scribal style, which was labeled QSP (Qumran Scribal Practice). According to Tov, these scrolls were written by the sects scribes. Tov believes that the other scrolls found at Qumran, labeled Non-QSP, were probably brought to the sect from the outside.

It turns out that all the scrolls we sampled whose nuclear DNA indicates that they belong to one cluster, namely that they are genetically close, were classified as QSP scrolls, whereas the Non-QSP scrolls belong to different clusters, Rechavi says.

Ben-Dov notes that in recent years the theory about the Qumran scribal practice came in for criticism, but now the researchers have shed new light on the subject. Until now this group of scrolls was characterized according to philological markers, and now we also have biological markers, he says.

In addition, the fact that no genetic similarity was found between the external scrolls and the first cluster nor between any of those scrolls in the external cluster supports the hypothesis that the Non-QSP scrolls originated in various places throughout Judea. One of the copies of Songs of the Sabbath Sacrifice found in Qumran now turns out to belong to the second cluster as well.

This is further reinforcement for the hypothesis that the Songs was widespread outside the sects circles, Rechavi avers.

One of the reasons for the confusion about the connection between different scroll fragments stems from the way they were found. Only about a quarter of the scrolls were found in situ by archaeologists, while most were found by Bedouin and sold to researchers in the 1950s, with the sellers not always having an interest in saying exactly where the valuable antiquities had come from. Now, with the aid of the new genetic tools, the scientists are able to unravel part of the tangle, and identify mistakes of earlier researchers. For example, the study found that a fragment from Isaiah, which until now was cataloged as part of the Qumran scrolls, deviates genetically from all the other Qumran scrolls. This raises intriguing questions: Did the fragment really come from the Qumran caves, or perhaps from a place that hasnt yet been identified? Mizrahi notes, adding, Perhaps segments resembling it are still lurking among the 25,000 scroll fragments found to date.

What next? Pnina Shor, founder of the Dead Sea Scrolls Project unit in the Israel Antiquities Authority, who took part in the research study, notes that the authority is working to enlist state-of-the-art scientific tools in an effort to improve the deciphering and preservation of the scrolls. With the aid of international collaboration, the IAA is now drawing on tools such as artificial intelligence to make progress in assembling the physical and textual jigsaw puzzle. Another plan is to make use of a particle accelerator to read segments of a scroll that congealed, rendering it impossible to separate its layers. The IAA is also adopting the biological tools. The present study is proof of its feasibility, Shor says.

The study examined only a small number of the scrolls, but according to the scientists a promising path to solving the riddles residing in the Qumran scrolls lies in expanding the use of genetic analysis. The development of the methods that made the latest breakthroughs possible took years, but the researchers are convinced that the next stage will be far more rapid. Rechavi: I hope we will be able to sample a large number of scrolls and discover how to put the puzzle together.

According to Prof. Oren Harman, a historian of science from Bar-Ilan University, the use of ancient DNA is like the invention of a new tool, like the microscope or the telescope. It allows us to tell a new story, sometimes a different story from the one the archaeologists, anthropologists and historians told until now. Like every scientific tool, emphasizes Harman, who was not involved in the study, ancient DNA should also serve to solve good questions, and not stand on its own. Its important to remember that analysis of the results of studies that rely on ancient DNA is based on a statistical interpretation of the data, and that different interpretations are possible for the same data.

Prof. Pilpel, the molecular geneticist, notes that the researchers conclusions about the scrolls they examined appear to be solid. One of the reasons for this is the choice of scrolls that are of interest if it is shown that they are not connected to one another. It is easier to establish that two sections of skin do not belong to the same animal all you have to do is show that there are a certain number of differences in the DNA, and that can be done even if the genetic material that remains is of low quality.

The various Bible scholars surveyed by Haaretz all say they are certain that even if the biological information serves only to show that different scroll fragments do not match one another, there are many fascinating questions to ask with the use of this tool. There is hope of achieving a more accurate classification of the scrolls in the future, says Michael Segal. According to Ben-Dov, We [Bible scholars] have been wrestling with different theories for so many years, but biology is providing us with a new way to make our arguments.

Prof. Mizrahi sums up the field of scrolls research in the following way: We are adrift on an ocean of uncertainty, and scientific research creates a small island of probability in it. The more we increase knowledge, the more we discover more cogently how much we have left to discover.

View original post here:
DNA unlocks the secrets of the Dead Sea Scrolls - Haaretz

Read More...

What’s Next Innovation Challenge Sponsored by AARP Innovation Labs Names Finalists; Expert Judging Panel Will Determine Winners June 25 with Virtual…

June 12th, 2020 3:49 am

BERKELEY, Calif., June 11, 2020 /PRNewswire/ --One of the hallmarks of the What's Next Longevity Summits are the competitions where entrepreneurs in the $8.3 trillion longevity economy vie for prestige, seed money and distribution partner opportunities. Produced by Mary Furlong & Associates since 2003, this year's annual What's Next Longevity Venture Summitwill take the competitions to a new level with virtual judging panels and audience participation using an innovative onlineplatform, Countable.

The finalists in the What's Next Innovation Challenge sponsored by AARP Innovation Labs are:AudioCardio, Alango Wear & Hear; Active Life Hearing Loops, LLC; Asius Technologies, LLC; Yes Hearing; and Singular Hearing Inc. Chosen from a large field of applicants, these six companies offer the most disruptive solutions to drive adoption and usage of hearing aids for the millions over age 50 who have hearing impairment in the U.S.

"We're excited to sponsor the What's Next Innovation Challenge again this year and discover how entrepreneurs can help transform the lives of millions of older Americans living with hearing loss," said Jacqueline M. Baker, vice president of Startup Programming for AARP Innovation Labs. "Our mission is to empower people to choose how to live how they want as they age. We look forward to seeing who the top winners are who share this dream."

"There is no better event for these entrepreneurs helping to solve hearing loss that impacts one in three Americans between ages 65-74," said Mary Furlong, serial successful entrepreneur, author and producer of the What's Next Longevity Summits. "The entrepreneurial talent from this competition not only gets the attention from event attendees who can fund or distribute their innovation and help scale their business, but also gets the chance to go on to national awareness thanks to our sponsor, AARP Innovation Labs."

Each finalist will make their pitch to the expert judging panel consisting of longevity experts and investors: Dave Blanchard Hamilton CapTel, Abby Levy Primetime Partners and Jeannee Parker Martin LeadingAge California. The judges will vote collectively to determine the winner who will earn a spot at the AARP Innovation Labs Grand Pitch Finale in Washington, D.C. later this year.

The 2020 theme for the What's Next Longevity Venture Summit Business Plan Competition is "Technologies to Support the Needs of Older Adults in the Time of COVID-19." A panel of top investors in Silicon Valley, Washington, D.C. and corporate ventures will select the winning plan which receives $10,000 seed funding to pursue their innovation. Interested entrepreneurs still have time to submit their application by the deadline of Tuesday, June 30 at 11:59 pm PST here.

A select number of top entrepreneurs will be chosen to participate in the annual Pitch for Distribution competition. These entrepreneurs are given a 4-minute pitch to a panel of potential distribution partners for their innovation. The judging panel decides on whether or not to take a follow-up meeting with each entrepreneur.

Given the disruption of the coronavirus pandemic, the What's Next Longevity Venture Summit event will be a 3-day virtual event with on demand content including: more than 70 speakers, thought leader panel discussions, analyst research presentations, best practice and investor case studies and networking possibilities with leading investors, businesses, entrepreneurs, nonprofits, authors, analysts, media and marketing experts will join the virtual event powered by Countable.

The Countable platform reimagines a dynamic digital experience for event organizers and Participants as a content-first platform architected for actionability, audience engagement and measurable impact.

"Countable was founded to activate audiences and expand the ways in which we receive and engage with critical information and resources," said Bart Myers, founder & CEO of Countable. "We're thrilled to collaborate with Mary Furlong on the What's Next Longevity Venture Summit to deliver a unique experience to participants and sponsors in this year's event, and to do so in a manner that extends lasting value and engagement opportunities long into the future."

See the event agenda and full list of speakers and sponsors at: https://www.boomerventuresummit.com/

Media Contact:Lori Bitter241355@email4pr.com415-652-9884

Originally posted here:
What's Next Innovation Challenge Sponsored by AARP Innovation Labs Names Finalists; Expert Judging Panel Will Determine Winners June 25 with Virtual...

Read More...

Trending Now: Longevity and Anti-senescence Therapy Market Share, Growth, Demand, Trends, Region Wise Analysis of Top Players and Forecasts – Cole of…

June 12th, 2020 3:49 am

Longevity and Anti-senescence TherapyMarket 2020: Inclusive Insight

Los Angeles, United States, May 2020:The report titled Global Longevity and Anti-senescence Therapy Market is one of the most comprehensive and important additions to Alexareports archive of market research studies. It offers detailed research and analysis of key aspects of the global Longevity and Anti-senescence Therapy market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Longevity and Anti-senescence Therapy market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Longevity and Anti-senescence Therapy market is carefully analyzed and researched about by the market analysts.

Longevity and Anti-senescence Therapy Market competition by top manufacturers/ Key player Profiled: CohBar, TA Sciences, Unity Biotechnology, AgeX TherapeuticsInc, PowerVision Inc.

Get PDF Sample Copy of the Report to understand the structure of the complete report:(Including Full TOC, List of Tables & Figures, Chart) : https://www.alexareports.com/report-sample/869763

Global Longevity and Anti-senescence Therapy Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026. According to the latest report added to the online repository of Alexareports the Longevity and Anti-senescence Therapy market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2026.

Longevity and Anti-senescence Therapy Market Segment by Type covers: Hemolytic Drug Therapy, Gene Therapy, Immunotherapy, Other Stem Cell Therapies

Longevity and Anti-senescence Therapy Market Segment by Application covers:Hospital, Medical Service Institution, Drug and Device Sales

After reading the Longevity and Anti-senescence Therapy market report, readers get insight into:

*Major drivers and restraining factors, opportunities and challenges, and the competitive landscape*New, promising avenues in key regions*New revenue streams for all players in emerging markets*Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions*Demand and uptake patterns in key industries of the Longevity and Anti-senescence Therapy market*New research and development projects in new technologies in key regional markets*Changing revenue share and size of key product segments during the forecast period*Technologies and business models with disruptive potential

Based on region, the globalLongevity and Anti-senescence Therapy market has been segmented into Americas (North America ((the U.S. and Canada),) and Latin Americas), Europe (Western Europe (Germany, France, Italy, Spain, UK and Rest of Europe) and Eastern Europe), Asia Pacific (Japan, India, China, Australia & South Korea, and Rest of Asia Pacific), and Middle East & Africa (Saudi Arabia, UAE, Kuwait, Qatar, South Africa, and Rest of Middle East & Africa).

Key questions answered in the report:

What will the market growth rate of Longevity and Anti-senescence Therapy market?What are the key factors driving the global Longevity and Anti-senescence Therapy market size?Who are the key manufacturers in Longevity and Anti-senescence Therapy market space?What are the market opportunities, market risk and market overview of the Longevity and Anti-senescence Therapy market?What are sales, revenue, and price analysis of top manufacturers of Longevity and Anti-senescence Therapy market?Who are the distributors, traders, and dealers of Longevity and Anti-senescence Therapy market?What are the Longevity and Anti-senescence Therapy market opportunities and threats faced by the vendors in the global Longevity and Anti-senescence Therapy industries?What are sales, revenue, and price analysis by types and applications of Longevity and Anti-senescence Therapy market?What are sales, revenue, and price analysis by regions of Longevity and Anti-senescence Therapy industries?

GetExclusive discount on this report now at https://www.alexareports.com/check-discount/869763

Table of ContentsSection 1 Longevity and Anti-senescence Therapy Product DefinitionSection 2 Global Longevity and Anti-senescence Therapy Market Manufacturer Share and Market Overview2.1 Global Manufacturer Longevity and Anti-senescence Therapy Shipments2.2 Global Manufacturer Longevity and Anti-senescence Therapy Business Revenue2.3 Global Longevity and Anti-senescence Therapy Market Overview2.4 COVID-19 Impact on Longevity and Anti-senescence Therapy IndustrySection 3 Manufacturer Longevity and Anti-senescence Therapy Business Introduction3.1 CohBar Longevity and Anti-senescence Therapy Business Introduction3.1.1 CohBar Longevity and Anti-senescence Therapy Shipments, Price, Revenue and Gross profit 2014-20193.1.2 CohBar Longevity and Anti-senescence Therapy Business Distribution by Region3.1.3 CohBar Interview Record3.1.4 CohBar Longevity and Anti-senescence Therapy Business Profile3.1.5 CohBar Longevity and Anti-senescence Therapy Product Specification3.2 TA Sciences Longevity and Anti-senescence Therapy Business Introduction3.2.1 TA Sciences Longevity and Anti-senescence Therapy Shipments, Price, Revenue and Gross profit 2014-20193.2.2 TA Sciences Longevity and Anti-senescence Therapy Business Distribution by Region3.2.3 Interview Record3.2.4 TA Sciences Longevity and Anti-senescence Therapy Business Overview3.2.5 TA Sciences Longevity and Anti-senescence Therapy Product Specification3.3 Unity Biotechnology Longevity and Anti-senescence Therapy Business Introduction3.3.1 Unity Biotechnology Longevity and Anti-senescence Therapy Shipments, Price, Revenue and Gross profit 2014-20193.3.2 Unity Biotechnology Longevity and Anti-senescence Therapy Business Distribution by Region3.3.3 Interview Record3.3.4 Unity Biotechnology Longevity and Anti-senescence Therapy Business Overview3.3.5 Unity Biotechnology Longevity and Anti-senescence Therapy Product Specification3.4 AgeX TherapeuticsInc Longevity and Anti-senescence Therapy Business Introduction3.5 PowerVision Inc. Longevity and Anti-senescence Therapy Business IntroductionSection 4 Global Longevity and Anti-senescence Therapy Market Segmentation (Region Level)4.1 North America Country4.1.1 United States Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.1.2 Canada Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.2 South America Country4.2.1 South America Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.3 Asia Country4.3.1 China Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.3.2 Japan Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.3.3 India Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.3.4 Korea Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.4 Europe Country4.4.1 Germany Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.4.2 UK Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.4.3 France Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.4.4 Italy Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.4.5 Europe Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.5 Other Country and Region4.5.1 Middle East Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.5.2 Africa Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.5.3 GCC Longevity and Anti-senescence Therapy Market Size and Price Analysis 2014-20194.6 Global Longevity and Anti-senescence Therapy Market Segmentation (Region Level) Analysis 2014-20194.7 Global Longevity and Anti-senescence Therapy Market Segmentation (Region Level) AnalysisSection 5 Global Longevity and Anti-senescence Therapy Market Segmentation (Product Type Level)5.1 Global Longevity and Anti-senescence Therapy Market Segmentation (Product Type Level) Market Size 2014-20195.2 Different Longevity and Anti-senescence Therapy Product Type Price 2014-20195.3 Global Longevity and Anti-senescence Therapy Market Segmentation (Product Type Level) AnalysisSection 6 Global Longevity and Anti-senescence Therapy Market Segmentation (Industry Level)6.1 Global Longevity and Anti-senescence Therapy Market Segmentation (Industry Level) Market Size 2014-20196.2 Different Industry Price 2014-20196.3 Global Longevity and Anti-senescence Therapy Market Segmentation (Industry Level) AnalysisSection 7 Global Longevity and Anti-senescence Therapy Market Segmentation (Channel Level)7.1 Global Longevity and Anti-senescence Therapy Market Segmentation (Channel Level) Sales Volume and Share 2014-20197.2 Global Longevity and Anti-senescence Therapy Market Segmentation (Channel Level) AnalysisSection 8 Longevity and Anti-senescence Therapy Market Forecast 2019-20248.1 Longevity and Anti-senescence Therapy Segmentation Market Forecast (Region Level)8.2 Longevity and Anti-senescence Therapy Segmentation Market Forecast (Product Type Level)8.3 Longevity and Anti-senescence Therapy Segmentation Market Forecast (Industry Level)8.4 Longevity and Anti-senescence Therapy Segmentation Market Forecast (Channel Level)Section 9 Longevity and Anti-senescence Therapy Segmentation Product Type9.1 Hemolytic Drug Therapy Product Introduction9.2 Gene Therapy Product Introduction9.3 Immunotherapy Product Introduction9.4 Other Stem Cell Therapies Product IntroductionSection 10 Longevity and Anti-senescence Therapy Segmentation Industry10.1 Hospital Clients10.2 Medical Service Institution Clients10.3 Drug and Device Sales ClientsSection 11 Longevity and Anti-senescence Therapy Cost of Production Analysis11.1 Raw Material Cost Analysis11.2 Technology Cost Analysis11.3 Labor Cost Analysis11.4 Cost OverviewSection 12 Conclusion

Do Inquiry About The Report Here: https://www.alexareports.com/send-an-enquiry/869763

About Us:Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing a decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data.

Contact Us:Alexa ReportsPh no: +1-408-844-4624Email: [emailprotected]Site: https://www.alexareports.com

Read more from the original source:
Trending Now: Longevity and Anti-senescence Therapy Market Share, Growth, Demand, Trends, Region Wise Analysis of Top Players and Forecasts - Cole of...

Read More...

Marriage longevity: What’s the secret to a long, happy union? – The New Times

June 12th, 2020 3:49 am

Her Majesty the Queen of England and the Duke of Edinburgh looked frail and aged in the latest photo released by Buckingham Palace to mark Prince Philips 99th birthday. For a couple that has been under constant scrutiny by the public and media, and with a lot of rules to observe, it appears to me like they never or cannot remember when they last used the terms darling or sweetheart in reference to each other. It has been a lifetime of maintaining royal stature; I can hardly trace a photo of the two holding hands yet their photos date as far back as the 1940s.

As the Duke turned 99, I wondered how it has been for him to be married to 94-year-old Queen Elizabeth for 73 years a whole 73 years! There is an 83-year-old man who is thrice divorced, and in fact two of those divorces happened within 14 months.

For long, I have watched documentaries and read articles about the two. It is obvious that the husband accepted his place in the marriage and got comfortable in his skin. In some societies when a woman appears to be more successful, or enjoying a little bit more freedom, people will say the husband has been sat on, he has no say. It is possible Prince Philip heard this too but did he let it deter him? No.

The couple has lived and travelled together for long but as age caught up, Prince Philip retired from royal duties and effectively went to live at Sandrigham Estate located about 100 miles away from the Queen who resides either at Buckingham Palace or Windsor. I guess that is fine, they are an old couple. There are 45 year olds who dont share a bedroom or home.

According to royal observers and analysts, thanks to Covid-19, the Queen and her husband were reunited and have been living under the same roof for three months. It is the first time in years that they have stayed together for that long without being separated. During this time it is suspected they share either lunch or dinner together then spend the rest of the time separately carrying out individual activities, which for the Queen include receiving and reading letters as well as reviewing official documents sent to her.

What is their secret to a long marriage? One of the reasons cited is the fact that they are of differing personalities, the two of them did not try to change each other, they accepted and married who they saw and fell in love with. As prominent as she is, the Queen is more laid back compared to her husband. Whereas the present day woman or wife is a bit more confrontational compared to their mother and grandmother, it is said the Queen is much less confrontational. I picture her walking out of a room as soon as she sees Philips mood change. They also attributed the longevity of their marriage to tolerance and patience, hmmm, so 1800. No wonder divorce rates have increased the current population is less tolerant of a lot of things.

With several possible reasons advanced, I identified for me what was the most important secret to their successful marriage; it is the fact that they spend a lot more time apart than together. Stop those things of I want to see you more often. Absence makes the heart grow fonder. Spend lengthy periods without seeing each other and stay married for 73 years, in this day and age it is a huge achievement.

editor@newtimesrwanda.com

See more here:
Marriage longevity: What's the secret to a long, happy union? - The New Times

Read More...

Longevity And Anti-Senescence Therapy Market Worldwide Growth Survey Size COVID-19 2023 – Cole of Duty

June 12th, 2020 3:49 am

Theglobal longevity and anti-senescence therapies marketshould grow from $329.8 million in 2018 to $644.4 million by 2023 with a compound annual growth rate (CAGR) of 14.3% during 2018-2023.

Report Scope:

The scope of this report is broad and covers various therapies currently under trials in the global longevity and anti-senescence therapy market. The market estimation has been performed with consideration for revenue generation in the forecast years 2018-2023 after the expected availability of products in the market by 2023. The global longevity and anti-senescence therapy market has been segmented by the following therapies: Senolytic drug therapy, Gene therapy, Immunotherapy and Other therapies which includes stem cell-based therapies, etc.

Revenue forecasts from 2028 to 2023 are given for each therapy and application, with estimated values derived from the expected revenue generation in the first year of launch.

Request for Report Sample:https://www.trendsmarketresearch.com/report/sample/11698

The report also includes a discussion of the major players performing research or the potential players across each regional longevity and anti-senescence therapy market. Further, it explains the major drivers and regional dynamics of the global longevity and anti-senescence therapy market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors and potential entrants in the global longevity and anti-senescence therapy market.

Report Includes:

71 data tables and 40 additional tables An overview of the global longevity and anti-senescence therapy market Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023 Country specific data and analysis for the United States, Canada, Japan, China, India, U.K., France, Germany, Spain, Australia, Middle East and Africa Detailed description of various anti-senescence therapies, such as senolytic drug therapy, gene therapy, immunotherapy and other stem cell therapies, and their influence in slowing down aging or reverse aging process

Coverage of various therapeutic drugs, devices and technologies and information on compounds used for the development of anti-ageing therapeutics A look at the clinical trials and expected launch of anti-senescence products Detailed profiles of the market leading companies and potential entrants in the global longevity and anti-senescence therapy market, including AgeX Therapeutics, CohBar Inc., PowerVision Inc., T.A. Sciences and Unity Biotechnology

Summary

Global longevity and anti-senescence therapy market deals in the adoption of different therapies and treatment options used to extend human longevity and lifespan. Human longevity is typically used to describe the length of an individuals lifetime and is sometimes used as a synonym for life expectancy in the demography. Anti-senescence is the process by which cells stop dividing irreversibly and enter a stage of permanent growth arrest, eliminating cell death. Anti-senescence therapy is used in the treatment of senescence induced through unrepaired DNA damage or other cellular stresses.

Global longevity and anti-senescence market will witness rapid growth over the forecast period (2018-2023) owing to an increasing emphasis on Stem Cell Research and an increasing demand for cell-based assays in research and development.

An increasing geriatric population across the globe and a rising awareness of antiaging products among generation Y and later generations are the major factors expected to promote the growth of global longevity and anti-senescence market. Factors such as a surging level of disposable income and increasing advancements in anti-senescence technologies are also providing traction to the global longevity and anti-senescence market growth over the forecast period (2018-2023).

According to the National Institutes of Health (NIH), the total geriatric population across the globe in 2016 was over REDACTED. By 2022, the global geriatric population (65 years and above) is anticipated to reach over REDACTED. An increasing geriatric population across the globe will generate huge growth prospectus to the market.

Senolytics, placenta stem cells and blood transfusions are some of the hot technologies picking up pace in the longevity and anti-anti-senescence market. Companies and start-ups across the globe such as Unity Biotechnology, Human Longevity Inc., Calico Life Sciences, Acorda Therapeutics, etc. are working extensively in this field for the extension of human longevity by focusing on study of genomics, microbiome, bioinformatics and stem cell therapies, etc. These factors are poised to drive market growth over the forecast period.

Global longevity and anti-senescence market is projected to rise at a CAGR of REDACTED during the forecast period of 2018 through 2023. In 2023, total revenues are expected to reach REDACTED, registering REDACTED in growth from REDACTED in 2018.

The report provides analysis based on each market segment including therapies and application. The therapies segment is further sub-segmented into Senolytic drug therapy, Gene therapy, Immunotherapy and Others. Senolytic drug therapy held the largest market revenue share of REDACTED in 2017. By 2023, total revenue from senolytic drug therapy is expected to reach REDACTED. Gene therapy segment is estimated to rise at the highest CAGR of REDACTED till 2023. The fastest growth of the gene therapy segment is due to the Large investments in genomics. For Instance; The National Human Genome Research Institute (U.S.) had a budget grant of REDACTED for REDACTED research projects in 2015, thus increasing funding to REDACTED for approximately REDACTED projects in 2016.

More Info of Impact [emailprotected]https://www.trendsmarketresearch.com/report/covid-19-analysis/11698

See the original post here:
Longevity And Anti-Senescence Therapy Market Worldwide Growth Survey Size COVID-19 2023 - Cole of Duty

Read More...

Reese Witherspoon: Love, Live And Bake Biscuits – Longevity LIVE

June 12th, 2020 3:49 am

Reese Witherspoon is an extraordinary mix of a modern-day Hollywood role model and the girl next door. My grandmother Dorothea always said that it was a combination of beauty and strength that made Southern women whiskey in a teacup. We may be delicate and ornamental on the outside, but inside were strong and fiery. We all have a lot to learn from Southern culture, she writes in her debut book, Whiskey in a Teacup.

The book has been met with mixed reviews. This is to be expected, given the difficult history of the South. However, it also enjoyed the respect many have for Reeses outspoken views and work to achieve recognition for womens rights in the entertainment industry. Most would agree, though, that she has a knack for finding joy in and appreciation of the simpler things in life: happiness, health, family, talent and beauty.

Reese is an inspiration to thousands of women worldwide because of her drive for success and female entrepreneurship. Her hands may be full, being a mother and a wife, but she has also had a wildly successful career as an actor, producer, entrepreneur, and philanthropist. How she managed to achieve so much and still carve out pumpkins for her three children on Halloween must have something to do with her Southern roots.

This is what makes her role as Elizabeth Ardens Storyteller-in-Chief so compelling, and why her March On campaign in support of UN Women meant so much more than most lipstick launches. And then there is also her Southern-inspired line of clothing, accessories and home dcor, called Draper James, which launched in 2015. Despite it all, this 43-year-old doesnt look as if she has aged a day in 30 years.

Although the actor is new to authoring books, she is no stranger to reading them. She loves reading. Her best screenings, such as Big Little Lies, Gone Girl, and the upcoming Little Fires Everywhere or Luckiest Girl Alive, are adaptations of books. Born in New Orleans and raised in Nashville, Tennessee, Reese says her Southern heritage informs her whole life. She believes your home and childhood have a major impact on the way you choose to live your life. She says sharing the gospel of Southern living is a beautiful obsession of hers. The South follows her everywhere she goes: bluegrass country music, big holiday parties, and Kentucky Derbies. Jugs of Dorotheas Sun Tea, Dorotheas Brined-and-Battered Fried Chicken, Vegetable Plate-in-a-Jar and Brother Johns Ribs. Brunches, Steel Magnolias, and monograms.

Reese always tries to find the little joys in life. Many of us spend our days on autopilot, without stopping for a moment to soak it all in. When you do this for long enough, its easy to forget who you are and that there is no place like home. No matter where you end up, its good to remind yourself where you come from.

Reese prides herself on being welcoming, hospitable and warm. She treasures friendship and holds her family and community close to her heart. However successful she gets or whatever city she finds herself in, she always returns to her roots. More importantly, Southerners never exclude anyone, and they always remember their manners. They certainly know how to throw a good dinner party!

Reese says her Southern heritage shows in how she entertains, decorates her home and makes holidays special for her kids not to mention how she talks, dances and does her hair. I bet you would never have guessed that she uses hot rollers to style her hair every day. It may be an old technique, but Reeses hair always looks fabulous.

From decorating to entertaining, cooking, dressing and taking care of her skin, Reese is a natural at looking her best. She says she has her grandmother, Dorothea, to thank for her style choices and makeup skills.

Dorothea always taught her to dress appropriately and to get out of her sweatpants by 10 oclock latest because sweatpants are for sweating in only. More importantly, she learned that you should always choose to wear what makes you feel good, rather than follow fashion trends. You also need to know how to shop for the silhouette, color, and print that suits you best. Reese is blonde, so she has bright colors in her closet and usually opts for a fit and flare silhouette.She believes your makeup should always look natural. If you have freckles, you should still be able to see them through your foundation and powder. And lipstick goes a long way. She is obsessed with lipstick. After all, it makes her feel ready for the day and the world especially red because its a powerful political symbol.

Reese believes every woman should stop looking at or following accounts on Instagram that dont make them feel good. One standard of beauty doesnt exist. Instead, women should look at people or brands that stand for different expressions of what women are.

Beauty is not just about what is on the outside; its about how you feel. She thinks a lot goes into discovering the best version of yourself, and that isnt only what youre putting on your skin and how youre taking care of yourself; its about what you are reading, too. The messages you choose to consume make you who you are.

But even Reese admits to seeing wrinkles and fine lines as you age. That is why you should moisturize and use quality products that hydrate and nurture your skin. She cleanses her skin every night and never goes anywhere without an eyelash curler. And no, your skin products dont need to be expensive. There is so much choice today.

Reese dedicates time to her skincare routine, especially at night. She does this because its a wonderful way to close every day with something that is taking care of you. Moreover, she often has to remove heavy makeup after being on set. She uses coconut oil for her eye area and then retinol before her night cream. Reese has been using Retinol Ceramide Capsules by Elizabeth Arden for a year now, which she says has significantly improved her skin tone.

She believes cleansing and moisturizing should be part of your everyday ritual. That way, you will never have to do the heavy treatments. Dont skip the small steps, such as putting on sunscreen and keeping hydrated. Click on this link for our review of the Elizabeth Arden Prevage Progressive Renewal Treatment. With resurfacing ingredients like polyhydroxy acid (PHA) and alpha hydroxy acid (AHA), this facial peel helps to improve the appearance of dullness as well as combat the aging effects of sun damage.

Success and beauty require energy. That is why you need to focus on regular exercise and a holistic diet. Reese believes you cant support beautiful skin if you forget about your diet and lifestyle. What you eat plays a huge role in how your skin looks.

She drinks liters of water and has a green smoothie every day. She tells Harpers Bazaar that this includes a generous part of romaine lettuce and spinach, with an apple and banana. Then, when she has a breakout, chlorophyll drops in water help to get rid of spots.

Exercising with friends helps her to keep motivated. Although exercising is not her favorite thing, she aims for four to five days a week. While its not easy to wake up early, she must do it in the morning. If it gets to 11 oclock there will be no exercising.

She enjoys running outside two or three days a week, lifting weights twice a week, and yoga.

At Glamours Woman of the Year gala, Reese told the audience that, coming from a male-dominated industry, she now encourages every woman to stay away from a man who cannot manage an ambitious woman. And if there is a strong voice inside telling you to start something, dont keep quiet. Work hard and try to find an environment where it can grow into a strength.

If those around you dont appreciate your strength, its time to move on. Surround yourself with people who support you. If we encourage more women to be ambitious, the world will change, she says.

This article was first published in Longevity magazines South African bi-annual edition 2019/2020

If you enjoyed reading about lovely Reece, then you will enjoy reading how Jennifer Aniston stays so healthy and fit. Click here.

Continue reading here:
Reese Witherspoon: Love, Live And Bake Biscuits - Longevity LIVE

Read More...

The graying of the town – Powell Tribune

June 12th, 2020 3:49 am

Pat Stuart

The estimates look staggering. Two-thirds of the people over 65 years of age and three-fourths of those over 75 who have ever lived in all of time are alive, right now, this moment, today.

But this is just the beginning. In another 10 years by 2030 there will be more seniors over 65 than there are children under 15. By 2050, the number of seniors is expected to double again.

The numbers appear so overwhelming that we probably can take it as a given that the basic statement about the unprecedented numbers of elders is true.

This has huge consequences for a society that currently marginalizes seniors and worships youth. As for the economy, its changing even as we speak.

Right now, according to the AARP, 83% of American household wealth is held by people over 50, while older seniors (80 and over), hog most of the wealth held by the top 1%ers.

Their impact on the economy is so powerful that its spawned a new term: the Longevity Economy.

What does this mean? For openers, the Longevity Economy age group are staying employed longer, spending more money, generating tax revenue, driving entrepreneurship and investment, and are avid consumers of recreation and leisure activities.

Are they competition for younger workers? Analysts say, no. Instead, they claim that these seniors add value to our communities by finding new ways to complement the rest of the workforce. And, of course, seniors dominate the volunteer economy, boosting a communitys social capital.

Here at home

The Longevity Economy, in fact, is changing us in Park County.

A quarter of Park Countys current total population is over 65. Since another quarter is under 18 years of age, that means the current age ratio of those contributing to our local economy is 2:1; that is two (18 through 64 years of age) to one (65 and older).

In a sense, I see myself and a lot of my friends in this picture. Some of us grew up here, were part of the local economy, and sent our children to local schools. Others, though, as much as we loved our homes here, left to find work elsewhere only returning when we had a retirement income for support. Still others visited here as tourists, loved what they saw, and made this their retirement home.

All of us, health permitting, fit the larger national picture.

We volunteer and keep many of the service organizations functioning and their missions successful. We have hobby businesses like sales of our crafts or, in my case, books. We teach our own skills to others. And, mostly, we do that without recompense to ourselves while the people we teach go on to use their new skills to earn a livelihood.

Senior spending

Perhaps most importantly, we spend. Most of our retirement income enters the state from outside sources and, then, is spread around our communities.

Were the customers that help keep local businesses afloat,

Were the majority users of health care; ones who can pay our medical bills and are responsible for the presence of a large and vibrant medical community.

Were payers of property and sales taxes that contribute to keeping our local government services robust.

Were the backbone of almost all the churches in the area, helping maintain our moral and spiritual fiber.

Consider further that most retirees have incomes that are largely protected from the current (or any other) economic slump, and all are covered by health insurance. While traditional working age families are struggling, the majority of our seniors can continue to meet their mortgage schedules, shop for groceries, volunteer, order take-out from otherwise closed restaurants, pay their bills, buy gas and pay taxes. In short, theyre a stable economic unit.

To balance the picture

Still, weve worried about the number of retirees moving into the area, giving us an unbalanced demographic. As much as our gray-haired coterie contributes to the economy, they generally arent the ones who (for example) support the schools and give us a vital educational system. They dont open and run brick-and-mortar businesses that give us a vibrant downtown. Etc.

There are good, solid reasons why every community needs a balanced age demographic.

That said, its almost inevitable that our home-grown population of seniors will double as the national figure does. We can also expect to attract more retirees. Should we discourage or encourage this?

Thats a question our leaders will be grappling with in the coming years. The trick for them is going to be to keep a balance. Gray is good. But only when well-mixed.

Read more:
The graying of the town - Powell Tribune

Read More...

‘Once in a lifetime’ 20-ft. plant about to bloom in Nags Head – The Coastland Times – The Coastland Times

June 12th, 2020 3:49 am

Shirley Lutz has been waiting for 20 years for her century plant to bloom.

Located on S. Pamlico Way in Nags Head Cove, Lutzs century plant will only bloom once in its lifetime. The longevity of this type of plant, a member of the asparagus family, is around 25 years.

Once used for medicines, fiber, needles and food, this was an important plant for indigenous people.

The plant has grown almost overnight, according to Lutz, and now sits about 20-ft. off the ground. Lutz invites anyone who wants to come see her once in a lifetime blooming plant to drive by her garden.

READ ABOUT MORE COMMUNITY NEWS AND EVENTS HERE,

RECENT HEADLINES:

Local trumpeter Eric Williams shares his journey to serving with Armys Jazz Ambassadors

Muse Originals hits the road

Read the original here:
'Once in a lifetime' 20-ft. plant about to bloom in Nags Head - The Coastland Times - The Coastland Times

Read More...

Page 507«..1020..506507508509..520530..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick